{"gene":"LBP","run_date":"2026-04-28T18:30:27","timeline":{"discoveries":[{"year":2016,"finding":"Reconstitution of the complete LPS transfer cascade in vitro revealed that a single LBP molecule binds longitudinally to LPS micelles and catalyzes multiple rounds of LPS transfer to CD14 via electrostatic interactions; CD14 rapidly dissociates from the LBP-LPS complex after receiving LPS, and the single LPS molecule on CD14 is then transferred to TLR4-MD2 in a TLR4-dependent manner. Structural determinants on LBP critical for LPS binding and transfer were defined by electron microscopy and single-molecule TIRF fluorescence analysis.","method":"In vitro reconstitution of LPS transfer cascade, negative-stain electron microscopy, single-molecule TIRF fluorescence microscopy, mutagenesis of charged residues","journal":"Immunity","confidence":"High","confidence_rationale":"Tier 1 — full reconstitution in vitro with multiple orthogonal structural and single-molecule methods; replicated in companion BMB Reports paper","pmids":["27986454","28115037"],"is_preprint":false},{"year":1997,"finding":"LBP and BPI form physically distinct complexes with LPS: LBP disperses LPS aggregates (reducing apparent aggregate size), whereas BPI enhances sedimentation velocity and apparent size of LPS aggregates and inhibits LBP-LPS binding at very low BPI:LPS molar ratios, explaining their opposing functional consequences.","method":"Sedimentation analysis, light scattering, fluorescence spectroscopy of LPS-protein complexes","journal":"The Journal of Biological Chemistry","confidence":"High","confidence_rationale":"Tier 1 — multiple orthogonal biophysical methods on purified proteins; mechanistically definitive","pmids":["9228038"],"is_preprint":false},{"year":1998,"finding":"Structural analysis of conserved residues in BPI and LBP based on the BPI crystal structure identified that the most conserved regions form the interfaces of two apolar lipid-binding pockets, and a cluster of conserved positively charged residues at the tip of the N-terminal domain (corresponding to Lys42, 48, 92, 95, 99 in BPI) likely make electrostatic contacts with negatively charged LPS; the higher overall positive charge of BPI's N-terminal domain relative to LBP was proposed to underlie BPI's bactericidal activity.","method":"Comparative structural analysis using BPI crystal structure; sequence conservation mapping; homology modeling of human LBP","journal":"Protein Science","confidence":"Medium","confidence_rationale":"Tier 1 structure, but functional assignments are partly inferential from conservation; no LBP crystal structure","pmids":["9568897"],"is_preprint":false},{"year":2004,"finding":"In human coronary artery endothelial cells (HCAEC), TLR4 functions intracellularly, and LBP is required for efficient LPS uptake by facilitating internalization of LPS-CD14 complexes to intracellular TLR4-MD2. LBP-dependent uptake involves a scavenger receptor pathway.","method":"FACS, confocal microscopy, RT-PCR, functional activation assays; inhibitor experiments","journal":"FASEB Journal","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods in primary cells with functional readout; single lab","pmids":["15132988"],"is_preprint":false},{"year":2007,"finding":"LBP is required for LPS-induced disruption of tight junctions in cholangiocyte monolayers: siRNA knockdown of LBP (alongside TLR4 and c-Src) attenuated LPS-induced paracellular permeability increase and redistribution of ZO-1, occludin, and claudin proteins. LBP acts upstream of c-Src and myosin light chain kinase in the signaling cascade leading to ZO-1 tyrosine phosphorylation.","method":"siRNA knockdown, permeability assays, immunofluorescence, Western blot for phosphorylation","journal":"American Journal of Physiology - Gastrointestinal and Liver Physiology","confidence":"Medium","confidence_rationale":"Tier 2 — specific siRNA KD with defined molecular phenotype; single lab","pmids":["17446308"],"is_preprint":false},{"year":2005,"finding":"LBP transfers LPS to CD14 at low concentrations to enhance pro-inflammatory responses, but at high concentrations (as during acute-phase response) LBP inhibits LPS bioactivity. LBP also promotes LPS efflux from cell-surface mCD14 by transfer to plasma lipoproteins. Additionally, soluble CD14 can reverse monocyte LPS responses after binding without requiring extensive LPS release, whereas LBP inhibition after cell binding is independent of major LPS redistribution.","method":"In vitro cell activation assays, LPS binding/transfer experiments with purified proteins at varying concentrations","journal":"Journal of Endotoxin Research","confidence":"Medium","confidence_rationale":"Tier 2 — functional assays with purified components; replicated across labs for the dual stimulatory/inhibitory dose-dependent effect","pmids":["16176659","12803885"],"is_preprint":false},{"year":1999,"finding":"Monoclonal antibodies against murine LBP that either block LPS binding to LBP (class 1) or block LPS/LBP complex binding to CD14 (class 2) both suppressed LPS-induced TNF production and protected mice from lethal endotoxemia, demonstrating that LBP's critical function is to present LPS to CD14.","method":"Monoclonal antibody generation and characterization; in vivo LPS challenge model; TNF ELISA","journal":"Journal of Immunology","confidence":"High","confidence_rationale":"Tier 2 — mechanistic antibody blocking in vitro and in vivo; clear epistatic placement of LBP upstream of CD14","pmids":["10358200"],"is_preprint":false},{"year":2001,"finding":"Genetic deletion of LBP in mice with wild-type NRAMP1 renders them as susceptible to intraperitoneal Salmonella infection as NRAMP1-deficient mice, demonstrating that LBP is a critical non-redundant component of innate defense against Gram-negative bacterial infection in vivo.","method":"LBP knockout mouse model; in vivo bacterial infection challenge","journal":"Journal of Endotoxin Research","confidence":"High","confidence_rationale":"Tier 2 — clean genetic KO with defined infectious phenotype; in vivo epistasis with NRAMP1","pmids":["11753215"],"is_preprint":false},{"year":2001,"finding":"LBP is incorporated as a membrane-spanning protein (mLBP) in the cytoplasmic membrane of mononuclear cells in addition to its role as a soluble serum protein. In this membrane configuration, mLBP binds endotoxin aggregates and transfers them to transmembrane signaling proteins. Pre-formed soluble LBP-LPS complexes, in contrast, do not interact with membranes and lead to LPS neutralization. FRET spectroscopy showed endotoxin aggregates are intercalated into reconstituted membranes by mLBP.","method":"Patch-clamp electrophysiology on excised membrane patches, fluorescence resonance energy transfer (FRET) spectroscopy, RT-PCR, cytokine assays","journal":"Journal of Endotoxin Research","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods; membrane intercalation shown by FRET and electrophysiology; single lab","pmids":["12831460"],"is_preprint":false},{"year":2001,"finding":"LBP interacts with planar lipid bilayers by intercalating in a directed (asymmetric) orientation into negatively charged membranes, adopting a transmembrane configuration. After intercalation, both anti-LBP antibodies and LPS can bind to LBP on both sides of the bilayer. Pre-incubated LPS-LBP complexes do not interact with membranes.","method":"Electrical measurements on planar lipid bilayers (membrane current, potential, capacitance); antibody binding assays","journal":"Biological Chemistry","confidence":"Medium","confidence_rationale":"Tier 2 — reconstituted system with functional readout; single lab","pmids":["11347890"],"is_preprint":false},{"year":2005,"finding":"LBP binds to non-LPS bacterial amphiphilic compounds including lipoteichoic acid (LTA) from Gram-positive bacteria, LTA-like glycolipids from spirochetes, and lipopeptides from spirochetes, Mycobacterium, Gram-negative bacteria, and Mycoplasma, thereby modulating their ability to stimulate innate immune cells and their interaction with CD14.","method":"Binding assays; competitive LBP binding assay; cell stimulation assays","journal":"Journal of Endotoxin Research","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple ligands tested; replicated across labs for LTA (PMID 11828371); mechanistic breadth established","pmids":["16176661","11828371"],"is_preprint":false},{"year":1997,"finding":"Transcriptional activation of the LBP gene in hepatocytes requires intact STAT-3 binding sites in the LBP promoter, as demonstrated by nuclear run-on assays, RNA half-life measurements, and luciferase reporter assays with promoter mutation variants. IL-6 alone induces LBP transcription, while IL-1β augments the IL-6 effect.","method":"Nuclear run-on assays, RNA stability assays, luciferase reporter assays with LBP promoter deletion/mutation constructs","journal":"Cytokines, Cellular & Molecular Therapy","confidence":"Medium","confidence_rationale":"Tier 2 — reporter assays with mutagenesis; transcriptional mechanism defined","pmids":["9287245"],"is_preprint":false},{"year":1997,"finding":"The transcription factors AP-1 and C/EBPβ are required for LBP gene activation in hepatocytes: luciferase reporter assays and electromobility shift assays (EMSA) showed their binding to the LBP promoter, and stimulation with IL-1β, IL-6, TNF-α, and dexamethasone drives dose- and time-dependent LBP transcription.","method":"Luciferase reporter gene assays, electromobility shift assays (EMSA), Western blot","journal":"Immunobiology","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA plus reporter assays; single lab; two transcription factors identified","pmids":["9442384"],"is_preprint":false},{"year":2014,"finding":"LBP is a macrophage-specific LXR target gene: oxysterol treatment or modified-LDL loading induces LBP expression in macrophages but not liver in an LXR-dependent manner. Bone marrow transplant studies using LBP-/- donors showed markedly smaller atherosclerotic lesions and increased apoptosis in lesions, demonstrating that macrophage LBP promotes foam cell survival and atherogenesis without affecting cholesterol efflux.","method":"LXR agonist treatment, bone marrow transplantation, atherosclerosis lesion quantification, TUNEL staining, cholesterol efflux assay","journal":"Journal of Lipid Research","confidence":"High","confidence_rationale":"Tier 2 — in vivo KO transplant study with defined atherosclerosis phenotype plus in vitro mechanistic dissection; multiple methods","pmids":["24671012"],"is_preprint":false},{"year":2003,"finding":"A protease from the periodontal pathogen Prevotella intermedia cleaves both CD14 and LBP in a concentration-dependent manner, thereby reducing LPS virulence signaling. The enzyme is a membrane-associated 170-kDa cysteine protease that also cleaves membrane-associated CD14, as shown by decreased IL-1β mRNA induction in LPS-activated macrophage cell lines.","method":"Zymography, molecular mass analysis, class-specific inhibitor/activator profiling, RT-PCR for IL-1β mRNA","journal":"Archives of Microbiology","confidence":"Medium","confidence_rationale":"Tier 2-3 — biochemical characterization of cleavage plus functional consequence; single lab","pmids":["12728301"],"is_preprint":false},{"year":2020,"finding":"Hepatic LBP expression is induced by gut microbiota through MYD88-dependent signaling. LBP potentiates LPS-induced inhibition of insulin signaling in hepatocytes at low LPS concentrations, and this effect is abolished by the LBP-blocking peptide LBPK95A. CRISPR-Cas9-mediated hepatic Lbp knockdown and systemic LBPK95A treatment both improve systemic glucose homeostasis in mice.","method":"Liver transcriptomics in germ-free vs. conventionally-raised Myd88-KO mice; primary hepatocyte insulin signaling assays; CRISPR-Cas9 hepatic KD; pharmacological LBP blockade in vivo","journal":"Molecular Metabolism","confidence":"High","confidence_rationale":"Tier 2 — multiple in vivo genetic models plus in vitro mechanistic assay; multiple orthogonal approaches","pmids":["32305515"],"is_preprint":false},{"year":2023,"finding":"Gastric cancer-derived LBP activates the TLR4/NF-κB pathway in intrahepatic macrophages to promote TGF-β1 secretion, which activates hepatic stellate cells to form a fibrotic pre-metastatic niche in the liver. TGF-β1 also enhances migration and invasion of metastatic gastric cancer cells. Shown by Co-IP, mRNA sequencing of LBP-treated macrophages, and intrasplenic injection mouse models.","method":"Co-immunoprecipitation, mRNA sequencing, flow cytometry, immunofluorescence, Western blot, intrasplenic injection mouse LM model, Transwell assays","journal":"Journal of Experimental & Clinical Cancer Research","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple methods; pathway placement via TLR4/NF-κB/TGF-β1 axis; single lab","pmids":["37789385"],"is_preprint":false},{"year":2017,"finding":"LBP can reverse the amyloid (hypercoagulable) state of fibrin observed in plasma from type 2 diabetic patients with cardiovascular comorbidities, suggesting LBP neutralizes LPS-induced fibrin amyloidogenesis. The effect was demonstrated by scanning electron microscopy and confocal microscopy of clot ultrastructure.","method":"Scanning electron microscopy (SEM), confocal microscopy of clot ultrastructure; platelet-poor plasma from T2D patients treated with LBP","journal":"Scientific Reports","confidence":"Low","confidence_rationale":"Tier 3 — morphological assay only; no direct biochemical mechanism for LBP-fibrin interaction established","pmids":["28851981"],"is_preprint":false},{"year":2002,"finding":"Peptides corresponding to human LBP amino acid region 86–108 inhibit LPS-LBP interaction. Alanine-scanning of residues 86–99 identified Trp91 and Lys92 as indispensable for peptide-LPS binding; substitution of Arg94, Lys95, and Phe98 with Ala increased inhibitory potency, with the Lys95→Ala mutant most active in blocking LPS binding to LBP.","method":"Synthetic peptide alanine-scanning library; competitive LPS-binding assay; in vitro and in vivo LPS-response inhibition assays","journal":"Journal of Peptide Science","confidence":"Medium","confidence_rationale":"Tier 1-2 — systematic mutagenesis of LPS-binding region; functional validation in cell and animal assays","pmids":["11991204","14577844"],"is_preprint":false},{"year":2014,"finding":"Directed evolution of the LBP C-terminal CD14-binding region identified that a Thr287→Met mutation in LBP significantly improves the anti-endotoxin activity of derived peptides, suggesting that residue 287 of the LBP C-terminus plays an important role in LBP-CD14 interaction.","method":"Error-prone PCR phage display library; competitive CD14-binding screen; in vitro TNF-α/NF-κB assays; in vivo LPS-induced ARDS rat model","journal":"PloS One","confidence":"Medium","confidence_rationale":"Tier 1-2 — directed evolution plus functional in vitro and in vivo validation; single lab","pmids":["25025695"],"is_preprint":false},{"year":2024,"finding":"LBP deficiency in rats aggravates high-fat diet-induced NAFLD despite reduced inflammation. Integrative H3K27ac ChIP-seq and transcriptomics revealed that LBP loss alters the histone acetylome, with C/EBPβ identified as a pivotal transcription factor driving dysregulated H3K27ac and the lipid metabolism gene SCD as a downstream effector mediating NAFLD exacerbation.","method":"LBP-/- rat model; H3K27ac ChIP-seq; transcriptomics; integrative bioinformatic analysis; Western blot validation","journal":"Zoological Research","confidence":"Low","confidence_rationale":"Tier 3 — epigenomic association without direct biochemical demonstration of LBP-C/EBPβ interaction; single lab","pmids":["38114435"],"is_preprint":false},{"year":1998,"finding":"LBP and soluble CD14 play distinct roles in LPS uptake by cells: LBP enables LPS binding and uptake by cells expressing membrane CD14, while soluble CD14 confers LPS responsiveness on cells lacking membrane CD14. Cell activation and LPS uptake were found to be independent phenomena with different protein requirements.","method":"LPS binding assays, cellular uptake assays, cell activation assays using purified recombinant LBP and sCD14","journal":"Progress in Clinical and Biological Research","confidence":"Medium","confidence_rationale":"Tier 2 — purified proteins, cell-based functional assays; functional dissociation of uptake and activation","pmids":["9575548"],"is_preprint":false},{"year":2003,"finding":"During sepsis, LBP (in addition to sCD14) promotes transfer of cell-bound LPS to plasma lipoproteins (primarily HDL), thereby attenuating monocyte LPS responses. In severe sepsis, the dominant LPS acceptor shifts from HDL to an acute-phase VLDL fraction with altered composition including apolipoprotein E and serum amyloid A.","method":"LPS binding/transfer assays in undiluted human serum; septic patient plasma analysis; lipoprotein fractionation","journal":"Journal of Endotoxin Research","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional assays in human serum with patient samples; single lab; lipid transfer function demonstrated","pmids":["12803885"],"is_preprint":false},{"year":1998,"finding":"LBP and CD14 mRNA levels are co-induced in lung, kidney, and liver concurrently after cecal ligation and puncture (CLP) in mice, along with IL-1 mRNA, suggesting these organs become locally sensitized to a secondary LPS challenge through coordinated upregulation of the LPS recognition machinery.","method":"Northern blot, TaqMan fluorescent quantitative RT-PCR; CLP mouse model","journal":"The Journal of Surgical Research","confidence":"Low","confidence_rationale":"Tier 3 — mRNA expression data only; no direct mechanistic experiment beyond co-induction","pmids":["9695742"],"is_preprint":false}],"current_model":"LBP is a soluble acute-phase glycoprotein (~60 kDa) produced by hepatocytes under STAT-3, AP-1, and C/EBPβ transcriptional control in response to IL-6/IL-1β/TNF-α, and also expressed as a membrane-intercalated form in mononuclear cells; it binds longitudinally to LPS micelles and catalyzes multi-round transfer of LPS monomers to CD14 via electrostatic interactions, and the resulting CD14-LPS complex transfers LPS to TLR4-MD2 in a TLR4-dependent manner; at high concentrations LBP inhibits rather than enhances LPS signaling, and it additionally transfers LPS to plasma lipoproteins for neutralization, binds non-LPS bacterial amphiphiles (LTA, lipopeptides), intercalates into membranes to facilitate aggregate LPS transfer, is required in vivo for innate defense against Gram-negative bacteria, and in macrophages functions as an LXR target gene promoting foam cell survival and atherosclerosis while also potentiating LPS-driven inhibition of hepatic insulin signaling."},"narrative":{"teleology":[{"year":1997,"claim":"Defining LBP's transcriptional control resolved how acute-phase induction is regulated: STAT-3, AP-1, and C/EBPβ binding sites in the LBP promoter are required for hepatocyte transcription driven by IL-6, IL-1β, TNF-α, and dexamethasone.","evidence":"Nuclear run-on, RNA stability, luciferase reporter, and EMSA assays in hepatocyte lines","pmids":["9287245","9442384"],"confidence":"Medium","gaps":["No ChIP-seq confirmation of in vivo TF occupancy","Relative contribution of each TF at endogenous locus not quantified"]},{"year":1997,"claim":"Biophysical analysis established that LBP and BPI have opposing effects on LPS aggregates—LBP disperses while BPI stabilizes them—explaining their antagonistic roles in endotoxin biology.","evidence":"Sedimentation analysis, light scattering, and fluorescence spectroscopy with purified proteins","pmids":["9228038"],"confidence":"High","gaps":["No atomic-resolution structure of LBP–LPS complex","Relative kinetics of BPI competition in serum not determined"]},{"year":1998,"claim":"Homology modeling from the BPI crystal structure predicted that conserved positively charged residues at the N-terminal tip and two apolar lipid-binding pockets constitute the LPS-binding architecture of LBP.","evidence":"Comparative structural analysis and conservation mapping based on BPI crystal structure","pmids":["9568897"],"confidence":"Medium","gaps":["No experimental LBP crystal structure obtained","Functional roles of individual pockets not tested by mutagenesis at this stage"]},{"year":1999,"claim":"Monoclonal antibodies that block either LPS–LBP or LBP–CD14 interaction both protected mice from lethal endotoxemia, establishing in vivo that LBP's essential function is to present LPS to CD14.","evidence":"Blocking mAbs against murine LBP; in vivo LPS challenge and TNF ELISA","pmids":["10358200"],"confidence":"High","gaps":["Antibody epitopes not mapped to atomic resolution","Contribution of LPS-to-lipoprotein shunting not distinguished from CD14 presentation"]},{"year":2001,"claim":"Genetic deletion of LBP demonstrated it is a non-redundant innate defense factor: LBP-knockout mice were as susceptible to Salmonella as NRAMP1-deficient mice.","evidence":"LBP−/− mouse model with intraperitoneal Salmonella challenge","pmids":["11753215"],"confidence":"High","gaps":["Susceptibility to Gram-positive infection not tested","Compensatory pathways in the absence of LBP not characterized"]},{"year":2001,"claim":"Discovery that LBP also exists as a membrane-intercalated form (mLBP) in mononuclear cells expanded the functional model beyond a soluble opsonin, showing mLBP transfers LPS aggregates directly into membranes.","evidence":"Patch-clamp electrophysiology, FRET spectroscopy on reconstituted bilayers, and planar lipid bilayer assays","pmids":["12831460","11347890"],"confidence":"Medium","gaps":["Topology and stoichiometry of mLBP in native cell membranes not resolved","Relative contribution of mLBP versus soluble LBP to physiological signaling unknown"]},{"year":2002,"claim":"Alanine-scanning mutagenesis of LBP residues 86–108 identified Trp91 and Lys92 as indispensable for LPS binding and showed that the K95A substitution paradoxically enhanced anti-endotoxin potency of derived peptides, mapping the minimal LPS-interaction motif.","evidence":"Synthetic peptide library with competitive LPS-binding and in vitro/in vivo inhibition assays","pmids":["11991204","14577844"],"confidence":"Medium","gaps":["No co-crystal structure of peptide–LPS complex","Peptide effects not validated in full-length LBP context"]},{"year":2005,"claim":"The dose-dependent duality of LBP was mechanistically resolved: low-concentration LBP transfers LPS to CD14 for cell activation, whereas high-concentration LBP promotes LPS efflux to lipoproteins for neutralization, explaining the acute-phase regulatory logic.","evidence":"In vitro cell activation and LPS-transfer assays with purified proteins at varying concentrations; lipoprotein fractionation from septic plasma","pmids":["16176659","12803885"],"confidence":"Medium","gaps":["Threshold concentrations in vivo not defined","Structural basis for the concentration-dependent switch not determined"]},{"year":2005,"claim":"LBP's ligand repertoire was expanded beyond LPS to include lipoteichoic acid, spirochetal glycolipids, and bacterial lipopeptides, establishing it as a broad-spectrum pattern recognition cofactor.","evidence":"Competitive binding assays and cell stimulation assays with Gram-positive and atypical bacterial amphiphiles","pmids":["16176661","11828371"],"confidence":"Medium","gaps":["Binding affinities for non-LPS ligands not quantified comparatively","In vivo relevance for Gram-positive defense not shown genetically"]},{"year":2014,"claim":"Identification of LBP as a macrophage LXR target gene that promotes foam-cell survival and atherosclerosis linked LBP function to metabolic disease beyond infection, via a cholesterol-efflux-independent mechanism.","evidence":"LXR agonist treatment, bone marrow transplant of LBP−/− donors, atherosclerosis lesion quantification, TUNEL staining","pmids":["24671012"],"confidence":"High","gaps":["Downstream survival pathway in foam cells not identified","Whether LBP promotes atherogenesis through LPS-dependent or -independent signaling is unresolved"]},{"year":2016,"claim":"Full in vitro reconstitution of the LPS transfer cascade demonstrated that one LBP molecule catalyzes multiple rounds of LPS monomer extraction from micelles and delivery to CD14, which then hands off a single LPS to TLR4–MD-2 in a TLR4-dependent step, providing the complete quantitative mechanism.","evidence":"Reconstituted cascade with negative-stain EM and single-molecule TIRF fluorescence microscopy","pmids":["27986454","28115037"],"confidence":"High","gaps":["Atomic-resolution structure of the ternary LBP–LPS–CD14 transfer intermediate still lacking","Catalytic cycle rate constants not measured under physiological membrane conditions"]},{"year":2020,"claim":"Hepatic LBP was shown to be induced by gut microbiota via MYD88 and to potentiate LPS-driven inhibition of insulin signaling, connecting the LPS sensing axis to metabolic homeostasis; hepatic LBP knockdown or peptide blockade improved glucose tolerance.","evidence":"Germ-free vs. conventional and Myd88-KO mice; CRISPR hepatic KD; LBPK95A peptide in vivo; primary hepatocyte insulin signaling","pmids":["32305515"],"confidence":"High","gaps":["Direct molecular target of LBP in insulin signaling cascade not identified","Contribution of intestinal vs. hepatic LBP pools not separated"]},{"year":null,"claim":"A high-resolution crystal or cryo-EM structure of the LBP–LPS–CD14 transfer intermediate and the structural basis for LBP's concentration-dependent switch between pro-inflammatory transfer and lipoprotein shunting remain unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No atomic-resolution LBP structure solved","Mechanism of mLBP membrane insertion not structurally characterized","In vivo role of LBP in Gram-positive versus Gram-negative defense not genetically dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[0,1,2,10,18]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[0,5,6,21]},{"term_id":"GO:0140104","term_label":"molecular carrier activity","supporting_discovery_ids":[0,5,22]}],"localization":[{"term_id":"GO:0005576","term_label":"extracellular region","supporting_discovery_ids":[0,1,5,6,22]},{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[8,9]}],"pathway":[{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[0,6,7,10]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,3,4,15,16]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[13,16]}],"complexes":[],"partners":["CD14","TLR4","MD-2","BPI"],"other_free_text":[]},"mechanistic_narrative":"LBP is a soluble acute-phase glycoprotein that functions as the principal initiator of innate immune recognition of lipopolysaccharide (LPS) and other bacterial amphiphiles by catalyzing their transfer to CD14 and, subsequently, to the TLR4–MD-2 signaling complex [PMID:27986454, PMID:10358200]. A single LBP molecule binds longitudinally to LPS micelles and executes multiple rounds of monomer extraction via electrostatic interactions involving N-terminal residues Trp91/Lys92, while its C-terminal domain mediates CD14 docking; at high acute-phase concentrations LBP instead diverts LPS to plasma lipoproteins for neutralization, conferring a dose-dependent switch between pro- and anti-inflammatory outcomes [PMID:27986454, PMID:16176659, PMID:12803885]. LBP also recognizes lipoteichoic acid and bacterial lipopeptides, and in vivo LBP deficiency renders mice critically susceptible to Gram-negative infection [PMID:16176661, PMID:11753215]. Beyond classical innate immunity, macrophage-expressed LBP is an LXR target gene that promotes foam-cell survival and atherogenesis, and hepatic LBP potentiates LPS-driven inhibition of insulin signaling in a microbiota- and MYD88-dependent manner [PMID:24671012, PMID:32305515]."},"prefetch_data":{"uniprot":{"accession":"P18428","full_name":"Lipopolysaccharide-binding protein","aliases":[],"length_aa":481,"mass_kda":53.4,"function":"Plays a role in the innate immune response. Binds to the lipid A moiety of bacterial lipopolysaccharides (LPS), a glycolipid present in the outer membrane of all Gram-negative bacteria (PubMed:24120359, PubMed:7517398). Acts as an affinity enhancer for CD14, facilitating its association with LPS. Promotes the release of cytokines in response to bacterial lipopolysaccharide (PubMed:24120359, PubMed:7517398)","subcellular_location":"Secreted; Cytoplasmic granule membrane","url":"https://www.uniprot.org/uniprotkb/P18428/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/LBP","classification":"Not Classified","n_dependent_lines":0,"n_total_lines":1208,"dependency_fraction":0.0},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/LBP","total_profiled":1310},"omim":[{"mim_id":"617074","title":"SMITH-MAGENIS SYNDROME CHROMOSOME REGION, CANDIDATE GENE 8; SMCR8","url":"https://www.omim.org/entry/617074"},{"mim_id":"614110","title":"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 6; BPIFB6","url":"https://www.omim.org/entry/614110"},{"mim_id":"614109","title":"BPI FOLD-CONTAINING PROTEIN, FAMILY C; BPIFC","url":"https://www.omim.org/entry/614109"},{"mim_id":"614108","title":"BPI FOLD-CONTAINING PROTEIN, FAMILY B, MEMBER 2; BPIFB2","url":"https://www.omim.org/entry/614108"},{"mim_id":"609786","title":"GRAINYHEAD-LIKE 1; GRHL1","url":"https://www.omim.org/entry/609786"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"liver","ntpm":1320.7}],"url":"https://www.proteinatlas.org/search/LBP"},"hgnc":{"alias_symbol":["BPIFD2"],"prev_symbol":[]},"alphafold":{"accession":"P18428","domains":[{"cath_id":"3.15.10.10","chopping":"57-215","consensus_level":"high","plddt":94.4181,"start":57,"end":215},{"cath_id":"3.15.20.10","chopping":"220-478","consensus_level":"high","plddt":92.1714,"start":220,"end":478}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P18428","model_url":"https://alphafold.ebi.ac.uk/files/AF-P18428-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P18428-F1-predicted_aligned_error_v6.png","plddt_mean":90.56},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=LBP","jax_strain_url":"https://www.jax.org/strain/search?query=LBP"},"sequence":{"accession":"P18428","fasta_url":"https://rest.uniprot.org/uniprotkb/P18428.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P18428/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P18428"}},"corpus_meta":[{"pmid":"27986454","id":"PMC_27986454","title":"Reconstruction of LPS Transfer Cascade Reveals Structural Determinants within LBP, CD14, and TLR4-MD2 for Efficient LPS Recognition and Transfer.","date":"2016","source":"Immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27986454","citation_count":339,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14979920","id":"PMC_14979920","title":"Involution of the mouse mammary gland is associated with an immune cascade and an acute-phase response, involving LBP, CD14 and STAT3.","date":"2003","source":"Breast cancer research : BCR","url":"https://pubmed.ncbi.nlm.nih.gov/14979920","citation_count":301,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23262249","id":"PMC_23262249","title":"Non-selective betablocker therapy decreases intestinal permeability and serum levels of LBP and IL-6 in patients with cirrhosis.","date":"2012","source":"Journal of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/23262249","citation_count":257,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16176659","id":"PMC_16176659","title":"Modulatory effects of sCD14 and LBP on LPS-host cell interactions.","date":"2005","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/16176659","citation_count":236,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23349936","id":"PMC_23349936","title":"Determinants of serum concentrations of lipopolysaccharide-binding protein (LBP) in the adult population: the role of obesity.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23349936","citation_count":180,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22184060","id":"PMC_22184060","title":"Circulating lipopolysaccharide-binding protein (LBP) as a marker of obesity-related insulin resistance.","date":"2011","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/22184060","citation_count":175,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12887306","id":"PMC_12887306","title":"Bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP): structure, function and regulation in host defence against Gram-negative bacteria.","date":"2003","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/12887306","citation_count":162,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1373512","id":"PMC_1373512","title":"Function of lipopolysaccharide (LPS)-binding protein (LBP) and CD14, the receptor for LPS/LBP complexes: a short review.","date":"1992","source":"Research in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/1373512","citation_count":120,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9568897","id":"PMC_9568897","title":"The BPI/LBP family of proteins: a structural analysis of conserved regions.","date":"1998","source":"Protein science : a publication of the Protein Society","url":"https://pubmed.ncbi.nlm.nih.gov/9568897","citation_count":118,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15132988","id":"PMC_15132988","title":"Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses.","date":"2004","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/15132988","citation_count":116,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17446308","id":"PMC_17446308","title":"Lipopolysaccharide disrupts tight junctions in cholangiocyte monolayers by a c-Src-, TLR4-, and LBP-dependent mechanism.","date":"2007","source":"American journal of physiology. Gastrointestinal and liver physiology","url":"https://pubmed.ncbi.nlm.nih.gov/17446308","citation_count":109,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15106612","id":"PMC_15106612","title":"Meet the relatives: a family of BPI- and LBP-related proteins.","date":"2004","source":"Trends in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/15106612","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11828371","id":"PMC_11828371","title":"Cytokine induction by purified lipoteichoic acids from various bacterial species--role of LBP, sCD14, CD14 and failure to induce IL-12 and subsequent IFN-gamma release.","date":"2002","source":"European journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/11828371","citation_count":108,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28115037","id":"PMC_28115037","title":"Dynamic lipopolysaccharide transfer cascade to TLR4/MD2 complex via LBP and CD14.","date":"2017","source":"BMB reports","url":"https://pubmed.ncbi.nlm.nih.gov/28115037","citation_count":105,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24687809","id":"PMC_24687809","title":"Overfeeding increases postprandial endotoxemia in men: Inflammatory outcome may depend on LPS transporters LBP and sCD14.","date":"2014","source":"Molecular nutrition & food research","url":"https://pubmed.ncbi.nlm.nih.gov/24687809","citation_count":99,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9228038","id":"PMC_9228038","title":"Lipopolysaccharide (LPS)-binding proteins BPI and LBP form different types of complexes with LPS.","date":"1997","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/9228038","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21740312","id":"PMC_21740312","title":"Soluble CD14 subtype presepsin (sCD14-ST) and lipopolysaccharide binding protein (LBP) in neonatal sepsis: new clinical and analytical perspectives for two old biomarkers.","date":"2011","source":"The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians","url":"https://pubmed.ncbi.nlm.nih.gov/21740312","citation_count":91,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10353471","id":"PMC_10353471","title":"A novel acute-phase marker: lipopolysaccharide binding protein (LBP).","date":"1999","source":"Clinical chemistry and laboratory medicine","url":"https://pubmed.ncbi.nlm.nih.gov/10353471","citation_count":87,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11796638","id":"PMC_11796638","title":"Novel laminin-binding protein of Streptococcus pyogenes, Lbp, is involved in adhesion to epithelial cells.","date":"2002","source":"Infection and immunity","url":"https://pubmed.ncbi.nlm.nih.gov/11796638","citation_count":84,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21687569","id":"PMC_21687569","title":"In Critically Ill Patients, Serum Procalcitonin Is More Useful in Differentiating between Sepsis and SIRS than CRP, Il-6, or LBP.","date":"2011","source":"Critical care research and practice","url":"https://pubmed.ncbi.nlm.nih.gov/21687569","citation_count":81,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17218092","id":"PMC_17218092","title":"Adaptability of the Vitamin D nuclear receptor to the synthetic ligand Gemini: remodelling the LBP with one side chain rotation.","date":"2007","source":"The Journal of steroid biochemistry and molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/17218092","citation_count":76,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10358200","id":"PMC_10358200","title":"Monoclonal antibodies to murine lipopolysaccharide (LPS)-binding protein (LBP) protect mice from lethal endotoxemia by blocking either the binding of LPS to LBP or the presentation of LPS/LBP complexes to CD14.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10358200","citation_count":72,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10644752","id":"PMC_10644752","title":"Cloning of factors related to HIV-inducible LBP proteins that regulate steroidogenic factor-1-independent human placental transcription of the cholesterol side-chain cleavage enzyme, P450scc.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10644752","citation_count":68,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11001930","id":"PMC_11001930","title":"The transcriptional factor LBP-1c/CP2/LSF gene on chromosome 12 is a genetic determinant of Alzheimer's disease.","date":"2000","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11001930","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11753215","id":"PMC_11753215","title":"LBP, CD14, TLR4 and the murine innate immune response to a peritoneal Salmonella infection.","date":"2001","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/11753215","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21787344","id":"PMC_21787344","title":"LBP/BPI proteins and their relatives: conservation over evolution and roles in mutualism.","date":"2011","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/21787344","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15691911","id":"PMC_15691911","title":"Identification of cyanophage Ma-LBP and infection of the cyanobacterium Microcystis aeruginosa from an Australian subtropical lake by the virus.","date":"2005","source":"Applied and environmental microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/15691911","citation_count":61,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34295331","id":"PMC_34295331","title":"Effects of Lipopolysaccharide-Binding Protein (LBP) Single Nucleotide Polymorphism (SNP) in Infections, Inflammatory Diseases, Metabolic Disorders and Cancers.","date":"2021","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/34295331","citation_count":55,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29867910","id":"PMC_29867910","title":"Lyciumbarbarum Polysaccharide (LBP): A Novel Prebiotics Candidate for Bifidobacterium and Lactobacillus.","date":"2018","source":"Frontiers in microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/29867910","citation_count":53,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19617361","id":"PMC_19617361","title":"The laminin-binding protein Lbp from Streptococcus pyogenes is a zinc receptor.","date":"2009","source":"Journal of bacteriology","url":"https://pubmed.ncbi.nlm.nih.gov/19617361","citation_count":49,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15828022","id":"PMC_15828022","title":"Normal rat hepatic stellate cells respond to endotoxin in LBP-independent manner to produce inhibitor(s) of DNA synthesis in hepatocytes.","date":"2005","source":"Journal of cellular physiology","url":"https://pubmed.ncbi.nlm.nih.gov/15828022","citation_count":48,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14698217","id":"PMC_14698217","title":"Cloning and analyses of a BPI/LBP cDNA of the Atlantic cod (Gadus morhua L.).","date":"2004","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/14698217","citation_count":47,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30144513","id":"PMC_30144513","title":"Biomarkers of inflammation - LBP and TLR- predict progression of knee osteoarthritis in the DOXY clinical trial.","date":"2018","source":"Osteoarthritis and cartilage","url":"https://pubmed.ncbi.nlm.nih.gov/30144513","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12185532","id":"PMC_12185532","title":"Three new human members of the lipid transfer/lipopolysaccharide binding protein family (LT/LBP).","date":"2002","source":"Immunogenetics","url":"https://pubmed.ncbi.nlm.nih.gov/12185532","citation_count":45,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24367257","id":"PMC_24367257","title":"Parental transfer of the antimicrobial protein LBP/BPI protects Biomphalaria glabrata eggs against oomycete infections.","date":"2013","source":"PLoS pathogens","url":"https://pubmed.ncbi.nlm.nih.gov/24367257","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12427544","id":"PMC_12427544","title":"The BSP30 salivary proteins from cattle, LUNX/PLUNC and von Ebner's minor salivary gland protein are members of the PSP/LBP superfamily of proteins.","date":"2002","source":"Biochimica et biophysica acta","url":"https://pubmed.ncbi.nlm.nih.gov/12427544","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12555245","id":"PMC_12555245","title":"Association of the 3' UTR transcription factor LBP-1c/CP2/LSF polymorphism with late-onset Alzheimer's disease.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12555245","citation_count":44,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37789385","id":"PMC_37789385","title":"Gastric cancer-derived LBP promotes liver metastasis by driving intrahepatic fibrotic pre-metastatic niche formation.","date":"2023","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/37789385","citation_count":43,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9878528","id":"PMC_9878528","title":"LBP-p40 binds DNA tightly through associations with histones H2A, H2B, and H4.","date":"1998","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/9878528","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7836461","id":"PMC_7836461","title":"A novel LBP-1-mediated restriction of HIV-1 transcription at the level of elongation in vitro.","date":"1995","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/7836461","citation_count":42,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9695742","id":"PMC_9695742","title":"Tissue coexpression of LBP and CD14 mRNA in a mouse model of sepsis.","date":"1998","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/9695742","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11521082","id":"PMC_11521082","title":"A novel acute phase marker in cattle: lipopolysaccharide binding protein (LBP).","date":"2001","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/11521082","citation_count":41,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10759844","id":"PMC_10759844","title":"Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration.","date":"2000","source":"European journal of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10759844","citation_count":38,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29434315","id":"PMC_29434315","title":"Association of gut microbial communities with plasma lipopolysaccharide-binding protein (LBP) in premenopausal women.","date":"2018","source":"The ISME journal","url":"https://pubmed.ncbi.nlm.nih.gov/29434315","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"8954992","id":"PMC_8954992","title":"Analysis of nuclear localization of laminin binding protein precursor p40 (LBP/p40).","date":"1996","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/8954992","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12803885","id":"PMC_12803885","title":"Impact of sepsis-induced changes in plasma on LPS interactions with monocytes and plasma lipoproteins: roles of soluble CD14, LBP, and acute phase lipoproteins.","date":"2003","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/12803885","citation_count":37,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28851981","id":"PMC_28851981","title":"Lipopolysaccharide-binding protein (LBP) reverses the amyloid state of fibrin seen in plasma of type 2 diabetics with cardiovascular co-morbidities.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28851981","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24015877","id":"PMC_24015877","title":"Multiple unfolding pathways of leucine binding protein (LBP) probed by single-molecule force spectroscopy (SMFS).","date":"2013","source":"Journal of the American Chemical Society","url":"https://pubmed.ncbi.nlm.nih.gov/24015877","citation_count":35,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10725789","id":"PMC_10725789","title":"Fighting infection: the role of lipopolysaccharide binding proteins CD14 and LBP.","date":"1999","source":"Pathobiology : journal of immunopathology, molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10725789","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11347890","id":"PMC_11347890","title":"Interaction between lipopolysaccharide (LPS), LPS-binding protein (LBP), and planar membranes.","date":"2001","source":"Biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/11347890","citation_count":34,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29494603","id":"PMC_29494603","title":"Lipopolysaccharide-binding protein (LBP) can reverse the amyloid state of fibrin seen or induced in Parkinson's disease.","date":"2018","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/29494603","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15282311","id":"PMC_15282311","title":"Defective extraembryonic angiogenesis in mice lacking LBP-1a, a member of the grainyhead family of transcription factors.","date":"2004","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/15282311","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28241438","id":"PMC_28241438","title":"Lycium barbarum L. Polysaccharide (LBP) Reduces Glucose Uptake via Down-Regulation of SGLT-1 in Caco2 Cell.","date":"2017","source":"Molecules (Basel, Switzerland)","url":"https://pubmed.ncbi.nlm.nih.gov/28241438","citation_count":33,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16176661","id":"PMC_16176661","title":"Non-LPS targets and actions of LPS binding protein (LBP).","date":"2005","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/16176661","citation_count":32,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15588424","id":"PMC_15588424","title":"Cell activation by Toll-like receptors: role of LBP and CD14.","date":"2004","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/15588424","citation_count":31,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27392432","id":"PMC_27392432","title":"Reliability of plasma lipopolysaccharide-binding protein (LBP) from repeated measures in healthy adults.","date":"2016","source":"Cancer causes & control : CCC","url":"https://pubmed.ncbi.nlm.nih.gov/27392432","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24577527","id":"PMC_24577527","title":"LBP-4a improves insulin resistance via translocation and activation of GLUT4 in OLETF rats.","date":"2014","source":"Food & function","url":"https://pubmed.ncbi.nlm.nih.gov/24577527","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10477615","id":"PMC_10477615","title":"The nonintegrin laminin binding protein (p67 LBP) is expressed on a subset of activated human T lymphocytes and, together with the integrin very late activation antigen-6, mediates avid cellular adherence to laminin.","date":"1999","source":"Journal of immunology (Baltimore, Md. : 1950)","url":"https://pubmed.ncbi.nlm.nih.gov/10477615","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12831460","id":"PMC_12831460","title":"The role of membrane-bound LBP, endotoxin aggregates, and the MaxiK channel in LPS-induced cell activation.","date":"2003","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/12831460","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11283204","id":"PMC_11283204","title":"Genetic association of an LBP-1c/CP2/LSF gene polymorphism with late onset Alzheimer's disease.","date":"2001","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/11283204","citation_count":29,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39180723","id":"PMC_39180723","title":"Gut microbiota dysbiosis deteriorates immunoregulatory effects of tryptophan via colonic indole and LBP/HTR2B-mediated macrophage function.","date":"2024","source":"The ISME journal","url":"https://pubmed.ncbi.nlm.nih.gov/39180723","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21787332","id":"PMC_21787332","title":"Ovocalyxin-36 and other LBP/BPI/PLUNC-like proteins as molecular actors of the mechanisms of the avian egg natural defences.","date":"2011","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/21787332","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11605136","id":"PMC_11605136","title":"Lipopolysaccharide-binding protein (LBP) and markers of acute-phase response in patients with multiple organ dysfunction syndrome (MODS) following open heart surgery.","date":"2001","source":"The Thoracic and cardiovascular surgeon","url":"https://pubmed.ncbi.nlm.nih.gov/11605136","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10200442","id":"PMC_10200442","title":"The induction of apoptosis in HeLa cells by the loss of LBP-p40.","date":"1998","source":"Cell death and differentiation","url":"https://pubmed.ncbi.nlm.nih.gov/10200442","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30785504","id":"PMC_30785504","title":"LBP reduces theinflammatory injuryof kidney in septic rat and regulates the Keap1-Nrf2∕ARE signaling pathway1.","date":"2019","source":"Acta cirurgica brasileira","url":"https://pubmed.ncbi.nlm.nih.gov/30785504","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24671012","id":"PMC_24671012","title":"The macrophage LBP gene is an LXR target that promotes macrophage survival and atherosclerosis.","date":"2014","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/24671012","citation_count":26,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9733616","id":"PMC_9733616","title":"Pulmonary LPS-binding protein (LBP) upregulation following LPS-mediated injury.","date":"1998","source":"The Journal of surgical research","url":"https://pubmed.ncbi.nlm.nih.gov/9733616","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25329706","id":"PMC_25329706","title":"Antimicrobial activity of peptides derived from olive flounder lipopolysaccharide binding protein/bactericidal permeability-increasing protein (LBP/BPI).","date":"2014","source":"Marine drugs","url":"https://pubmed.ncbi.nlm.nih.gov/25329706","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19434318","id":"PMC_19434318","title":"Liquid Based Preparation (LBP) cytology versus Conventional Cytology (CS) in FNA samples from breast, thyroid, salivary glands and soft tissues. Our experience in Crete (Greece).","date":"2009","source":"Romanian journal of morphology and embryology = Revue roumaine de morphologie et embryologie","url":"https://pubmed.ncbi.nlm.nih.gov/19434318","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26799617","id":"PMC_26799617","title":"Serum LBP Is Associated with Insulin Resistance in Women with PCOS.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26799617","citation_count":25,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"7543211","id":"PMC_7543211","title":"Influence of CD14, LBP and BPI in the monocyte response to LPS of different polysaccharide chain length.","date":"1995","source":"Scandinavian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/7543211","citation_count":24,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"14577844","id":"PMC_14577844","title":"Inhibition of LPS-responses by synthetic peptides derived from LBP associates with the ability of the peptides to block LBP-LPS interaction.","date":"2003","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/14577844","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27273538","id":"PMC_27273538","title":"Arabidopsis LBP/BPI related-1 and -2 bind to LPS directly and regulate PR1 expression.","date":"2016","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/27273538","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34783213","id":"PMC_34783213","title":"Maternal Plasma and Amniotic Fluid LBP, Pentraxin 3, Resistin, and IGFBP-3: Biomarkers of Microbial Invasion of Amniotic Cavity and/or Intra-amniotic Inflammation in Women with Preterm Premature Rupture of Membranes.","date":"2021","source":"Journal of Korean medical science","url":"https://pubmed.ncbi.nlm.nih.gov/34783213","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38139003","id":"PMC_38139003","title":"Reduced Lipopolysaccharide-Binding Protein (LBP) Levels Are Associated with Non-Alcoholic Fatty Liver Disease (NAFLD) and Adipose Inflammation in Human Obesity.","date":"2023","source":"International journal of molecular sciences","url":"https://pubmed.ncbi.nlm.nih.gov/38139003","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26608112","id":"PMC_26608112","title":"The LBP/BPI multigenic family in invertebrates: Evolutionary history and evidences of specialization in mollusks.","date":"2015","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26608112","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"19707138","id":"PMC_19707138","title":"A common haplotype of the LBP gene predisposes to severe sepsis.","date":"2009","source":"Critical care medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19707138","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23742867","id":"PMC_23742867","title":"Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii.","date":"2013","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/23742867","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15471945","id":"PMC_15471945","title":"LBP proteins modulate SF1-independent expression of P450scc in human placental JEG-3 cells.","date":"2004","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/15471945","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17442589","id":"PMC_17442589","title":"mRNA expression patterns of the BPI/LBP molecule in the Atlantic cod (Gadus morhua L.).","date":"2006","source":"Fish & shellfish immunology","url":"https://pubmed.ncbi.nlm.nih.gov/17442589","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26297397","id":"PMC_26297397","title":"LBP/BPI homologue in Eisenia andrei earthworms.","date":"2015","source":"Developmental and comparative immunology","url":"https://pubmed.ncbi.nlm.nih.gov/26297397","citation_count":21,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"12728301","id":"PMC_12728301","title":"Cleavage of CD14 and LBP by a protease from Prevotella intermedia.","date":"2003","source":"Archives of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/12728301","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32305515","id":"PMC_32305515","title":"Hepatic expression of lipopolysaccharide-binding protein (Lbp) is induced by the gut microbiota through Myd88 and impairs glucose tolerance in mice independent of obesity.","date":"2020","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32305515","citation_count":19,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9287245","id":"PMC_9287245","title":"Control of transcriptional activation of the lipopolysaccharide binding protein (LBP) gene by proinflammatory cytokines.","date":"1997","source":"Cytokines, cellular & molecular therapy","url":"https://pubmed.ncbi.nlm.nih.gov/9287245","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11753213","id":"PMC_11753213","title":"CD14 and LBP in endotoxemia and infections caused by Gram-negative bacteria.","date":"2001","source":"Journal of endotoxin research","url":"https://pubmed.ncbi.nlm.nih.gov/11753213","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9442384","id":"PMC_9442384","title":"The transcriptional activation pattern of lipopolysaccharide binding protein (LBP) involving transcription factors AP-1 and C/EBP beta.","date":"1997","source":"Immunobiology","url":"https://pubmed.ncbi.nlm.nih.gov/9442384","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"21334452","id":"PMC_21334452","title":"Characterization of the Mycobacterium avium subsp. paratuberculosis laminin-binding/histone-like protein (Lbp/Hlp) which reacts with sera from patients with Crohn's disease.","date":"2011","source":"Microbes and infection","url":"https://pubmed.ncbi.nlm.nih.gov/21334452","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1847349","id":"PMC_1847349","title":"Expression of laminin and its receptor LBP-32 in human and rat hepatoma cells.","date":"1991","source":"Hepatology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/1847349","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37436939","id":"PMC_37436939","title":"Effect of time restricted feeding on anthropometric measures, eating behavior, stress, serum levels of BDNF and LBP in overweight/obese women with food addiction: a randomized clinical trial.","date":"2023","source":"Nutritional neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/37436939","citation_count":17,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"38114435","id":"PMC_38114435","title":"Loss of LBP triggers lipid metabolic disorder through H3K27 acetylation-mediated C/EBPβ- SCD activation in non-alcoholic fatty liver disease.","date":"2024","source":"Zoological research","url":"https://pubmed.ncbi.nlm.nih.gov/38114435","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"9575548","id":"PMC_9575548","title":"Roles for LBP and soluble CD14 in cellular uptake of LPS.","date":"1998","source":"Progress in clinical and biological research","url":"https://pubmed.ncbi.nlm.nih.gov/9575548","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27500282","id":"PMC_27500282","title":"Rosuvastatin Decreases Intestinal Fatty Acid Binding Protein (I-FABP), but Does Not Alter Zonulin or Lipopolysaccharide Binding Protein (LBP) Levels, in HIV-Infected Subjects on Antiretroviral Therapy.","date":"2016","source":"Pathogens & immunity","url":"https://pubmed.ncbi.nlm.nih.gov/27500282","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25025695","id":"PMC_25025695","title":"Directed evolution of an LBP/CD14 inhibitory peptide and its anti-endotoxin activity.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25025695","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32570947","id":"PMC_32570947","title":"Postprandial Endotoxin Transporters LBP and sCD14 Differ in Obese vs. Overweight and Normal Weight Men during Fat-Rich Meal Digestion.","date":"2020","source":"Nutrients","url":"https://pubmed.ncbi.nlm.nih.gov/32570947","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10079194","id":"PMC_10079194","title":"Ribosome-associated protein LBP/p40 binds to S21 protein of 40S ribosome: analysis using a yeast two-hybrid system.","date":"1999","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/10079194","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22640039","id":"PMC_22640039","title":"The inducible effect of LBP on maturation of dendritic cells and the related immune signaling pathways in hepatocellular carcinoma (HCC).","date":"2012","source":"Current drug delivery","url":"https://pubmed.ncbi.nlm.nih.gov/22640039","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"11991204","id":"PMC_11991204","title":"Identification of single amino acid residues essential for the binding of lipopolysaccharide (LPS) to LPS binding protein (LBP) residues 86-99 by using an Ala-scanning library.","date":"2002","source":"Journal of peptide science : an official publication of the European Peptide Society","url":"https://pubmed.ncbi.nlm.nih.gov/11991204","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16272261","id":"PMC_16272261","title":"Further evidence for LBP-1c/CP2/LSF association in Alzheimer's disease families.","date":"2005","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16272261","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25785448","id":"PMC_25785448","title":"Low levels of microbial translocation marker LBP are associated with sustained viral response after anti-HCV treatment in HIV-1/HCV co-infected patients.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25785448","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33505453","id":"PMC_33505453","title":"Facial Expression Recognition with LBP and ORB Features.","date":"2021","source":"Computational intelligence and neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/33505453","citation_count":13,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16189514","id":"PMC_16189514","title":"Towards a proteome-scale map of the human protein-protein interaction network.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/16189514","citation_count":2090,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16169070","id":"PMC_16169070","title":"A human protein-protein interaction network: a resource for annotating the proteome.","date":"2005","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/16169070","citation_count":1704,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22681889","id":"PMC_22681889","title":"The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts.","date":"2012","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/22681889","citation_count":973,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15635413","id":"PMC_15635413","title":"Nucleolar proteome dynamics.","date":"2005","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/15635413","citation_count":934,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15592455","id":"PMC_15592455","title":"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.","date":"2004","source":"Nature biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/15592455","citation_count":916,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29507755","id":"PMC_29507755","title":"VIRMA mediates preferential m6A mRNA methylation in 3'UTR and near stop codon and associates with alternative polyadenylation.","date":"2018","source":"Cell discovery","url":"https://pubmed.ncbi.nlm.nih.gov/29507755","citation_count":829,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11790298","id":"PMC_11790298","title":"Directed proteomic analysis of the human nucleolus.","date":"2002","source":"Current biology : CB","url":"https://pubmed.ncbi.nlm.nih.gov/11790298","citation_count":780,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"14702039","id":"PMC_14702039","title":"Complete sequencing and characterization of 21,243 full-length human cDNAs.","date":"2003","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/14702039","citation_count":754,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28302793","id":"PMC_28302793","title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.","date":"2017","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/28302793","citation_count":533,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23636399","id":"PMC_23636399","title":"Structures of the human and Drosophila 80S ribosome.","date":"2013","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/23636399","citation_count":481,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35271311","id":"PMC_35271311","title":"OpenCell: Endogenous tagging for the cartography of human cellular organization.","date":"2022","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/35271311","citation_count":432,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20020773","id":"PMC_20020773","title":"Global analysis of TDP-43 interacting proteins reveals strong association with RNA splicing and translation machinery.","date":"2010","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/20020773","citation_count":422,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15189156","id":"PMC_15189156","title":"The molecular mechanics of eukaryotic translation.","date":"2004","source":"Annual review of biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/15189156","citation_count":396,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25901680","id":"PMC_25901680","title":"Structure of the human 80S ribosome.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/25901680","citation_count":380,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16973587","id":"PMC_16973587","title":"The 37/67-kilodalton laminin receptor is a receptor for adeno-associated virus serotypes 8, 2, 3, and 9.","date":"2006","source":"Journal of virology","url":"https://pubmed.ncbi.nlm.nih.gov/16973587","citation_count":340,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2970671","id":"PMC_2970671","title":"The human laminin receptor is a member of the integrin family of cell adhesion receptors.","date":"1988","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/2970671","citation_count":323,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21145461","id":"PMC_21145461","title":"Dynamics of cullin-RING ubiquitin ligase network revealed by systematic quantitative proteomics.","date":"2010","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21145461","citation_count":318,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"2429301","id":"PMC_2429301","title":"Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin.","date":"1986","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/2429301","citation_count":283,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11054877","id":"PMC_11054877","title":"Integrins as receptors for laminins.","date":"2000","source":"Microscopy research and technique","url":"https://pubmed.ncbi.nlm.nih.gov/11054877","citation_count":278,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":47865,"output_tokens":6291,"usd":0.11898},"stage2":{"model":"claude-opus-4-6","input_tokens":9931,"output_tokens":3361,"usd":0.20052},"total_usd":0.645801,"stage1_batch_id":"msgbatch_01Mgbec4vM6c9vXht7JVJzss","stage2_batch_id":"msgbatch_01JkuuH5RB2BdJNsgnhjbC6s","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":59354,"output_tokens":6946,"usd":0.141126},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":9830,"output_tokens":2972,"usd":0.185175}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"LBP binds longitudinally to LPS micelles as a single molecule and catalyzes multi-round transfer of LPS to CD14 via electrostatic interactions; CD14 then transfers a single LPS molecule to TLR4-MD2 in a TLR4-dependent manner. Structural determinants on LBP and CD14 required for each step were defined by EM and single-molecule TIRF reconstitution.\",\n      \"method\": \"In vitro reconstitution of entire LPS transfer cascade, negative-stain electron microscopy, single-molecule TIRF fluorescence microscopy, mutational analysis of charged residues\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — full in vitro reconstitution with multiple orthogonal structural/single-molecule methods and mutational validation\",\n      \"pmids\": [\"27986454\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Single LBP molecule binds longitudinally to LPS micelle surface; multi-round binding/unbinding of CD14 to single LBP/LPS micelles is mediated by key charged residues on both LBP and CD14; single LPS bound to CD14 is subsequently transferred to TLR4/MD2 in a TLR4-dependent manner.\",\n      \"method\": \"Negative-stain electron microscopy visualization of intermediate complexes; single-molecule TIRF microscopy\",\n      \"journal\": \"BMB reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — independent summary/confirmation of reconstitution data from same group with EM and single-molecule approaches\",\n      \"pmids\": [\"28115037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LBP forms physically distinct complexes with LPS compared to BPI: LBP can disperse LPS aggregates into smaller forms (shown by sedimentation, light scattering, fluorescence), while BPI enhances LPS aggregate size and inhibits LBP-LPS binding even at very low BPI:LPS ratios.\",\n      \"method\": \"Sedimentation analysis, dynamic light scattering, fluorescence assays comparing LBP-LPS and BPI-LPS complexes\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple biophysical assays in vitro demonstrating mechanistic distinction between LBP and BPI complexes\",\n      \"pmids\": [\"9228038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Structure/function analysis using the BPI crystal structure as template reveals that conserved positively charged residues at the tip of the N-terminal domain (Lys 42, 48, 92, 95, 99 of BPI; equivalent positions in LBP) form the LPS-binding site through electrostatic interactions with LPS phosphate groups; conserved residues at tertiary structural interfaces create two apolar lipid-binding pockets.\",\n      \"method\": \"Comparative sequence analysis of 7 BPI/LBP sequences mapped onto BPI crystal structure; homology modelling of LBP\",\n      \"journal\": \"Protein science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 method (crystal structure-based) but applied as structural inference/modelling without direct LBP crystal structure or mutagenesis of LBP itself\",\n      \"pmids\": [\"9568897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In human coronary artery endothelial cells, TLR4 functions intracellularly; LBP enables LPS uptake and delivery to intracellular TLR4-MD2 at low LPS concentrations by facilitating LPS-CD14 complex internalization via a scavenger receptor pathway.\",\n      \"method\": \"FACS, confocal microscopy, RT-PCR, functional activation assays; manipulation of LBP presence/absence in cell culture\",\n      \"journal\": \"FASEB journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in cell-based system defining LBP role in intracellular LPS delivery, single lab\",\n      \"pmids\": [\"15132988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Monoclonal antibodies blocking LBP-LPS binding (class 1) or blocking LPS/LBP complex binding to CD14 (class 2) both suppressed LPS-induced TNF production and protected mice from lethal endotoxemia, confirming LBP functions sequentially: first binding LPS, then presenting the complex to CD14.\",\n      \"method\": \"Generation of rat anti-murine LBP mAbs of defined blocking classes; in vivo mouse endotoxemia model with TNF measurement\",\n      \"journal\": \"Journal of immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — functional antibody blocking in vitro and in vivo with mechanistically distinct antibody classes, replicates prior genetic data\",\n      \"pmids\": [\"10358200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LBP, CD14, and TLR4 are each individually required for innate defense against intraperitoneal Salmonella infection in mice; loss of any single gene causes susceptibility as severe as loss of NRAMP-1, placing LBP as a critical upstream component of the innate immune signaling cascade to TLR4.\",\n      \"method\": \"Genetic epistasis using LBP-/-, CD14-/-, TLR4-/- knockout mice on NRAMP-1 wild-type background; in vivo Salmonella infection model with survival readout\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout mouse models with defined infection phenotype, epistasis places LBP in pathway upstream of TLR4\",\n      \"pmids\": [\"11753215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LBP intercalates in a directed transmembrane orientation into negatively-charged planar lipid bilayers; after membrane binding, LBP can bind LPS and anti-LBP antibodies on both sides of the membrane, indicating a transmembrane configuration. Pre-formed LPS-LBP complexes do not interact with membranes.\",\n      \"method\": \"Electrical measurements (membrane current, potential, capacitance) on symmetric and asymmetric planar lipid bilayers with LBP, anti-LBP antibodies, and LPS addition\",\n      \"journal\": \"Biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 in vitro biophysical reconstitution, single lab, single method set\",\n      \"pmids\": [\"11347890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"LBP also exists as a membrane-bound transmembrane protein (mLBP) in the cytoplasmic membrane of mononuclear cells, where it binds endotoxin aggregates and transfers them to transmembrane signaling proteins. Soluble LBP-LPS complexes formed in serum prior to membrane contact lead to LPS neutralization rather than activation. Endotoxin in aggregated (not monomeric) state is intercalated into membranes by mLBP.\",\n      \"method\": \"RT-PCR for mLBP expression; FRET spectroscopy showing endotoxin aggregate intercalation into reconstituted membranes by mLBP; patch-clamp experiments on macrophage membranes; cell culture cytokine assays\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods including FRET, patch-clamp, and functional assays, single lab\",\n      \"pmids\": [\"12831460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"In undiluted human serum, LBP inhibits LPS-induced cytokine responses in monocytes that have already bound LPS, by a mechanism not requiring extensive LPS release from the cell (unlike sCD14). LPS binds transiently to monocytes and is released into plasma lipoproteins; during sepsis, LPS shifts from HDL to acute-phase VLDL-like lipoproteins as dominant acceptors.\",\n      \"method\": \"LPS binding and cytokine response assays in undiluted human and septic patient serum; lipoprotein fractionation; LPS transfer quantification\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional cell-based assays with defined mechanistic outcome and patient plasma, single lab\",\n      \"pmids\": [\"12803885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LBP binds not only LPS but also other amphiphilic bacterial compounds including lipoteichoic acid (LTA) from Gram-positive bacteria, LTA-like glycolipids from spirochetes, and lipopeptides from Mycoplasma, Mycobacterium, and Gram-negative bacteria, modulating their biological activity toward immune cells in an LBP-dependent manner.\",\n      \"method\": \"LBP competitive binding assay (IC50 measurement); TNF-alpha induction assays with LBP present/absent; review of prior experimental literature\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — binding assays and functional assays establishing broader substrate range, supported by multiple experimental observations across labs\",\n      \"pmids\": [\"16176661\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"LBP enhances TNF-alpha release from PBMCs in response to LPS but not LTA; LBP binds LTA with ~500-3230-fold lower affinity than LPS (IC50 in competitive LBP binding assay); sCD14 inhibits LTA-induced monokine production but cannot confer LTA responsiveness to endothelial cells, demonstrating differential roles for LBP/sCD14 in LPS vs. LTA recognition.\",\n      \"method\": \"Competitive LBP binding assay with purified LTA preparations; TNF-alpha cytokine release assays from human PBMC and whole blood with/without LBP\",\n      \"journal\": \"European journal of immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — in vitro binding competition and functional assays with defined readouts, single lab\",\n      \"pmids\": [\"11828371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LBP gene transcription in hepatocytes is activated by IL-6 (strongly) and synergistically by IL-1β combined with IL-6 and TNF-α; transcriptional activation involves the transcription factors AP-1 and C/EBPβ binding to the LBP promoter, as well as a STAT-3 binding acute-phase promoter motif that is essential for LBP induction.\",\n      \"method\": \"Nuclear run-on assays (transcriptional rate), RNA half-life experiments, 5'-flanking region cloning, luciferase reporter gene assays with promoter mutants, electromobility shift assays (EMSA)\",\n      \"journal\": \"Cytokines, cellular & molecular therapy / Immunobiology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple independent methods (nuclear run-on, luciferase reporters, EMSA) in two related publications identifying mechanism of LBP transcriptional regulation\",\n      \"pmids\": [\"9287245\", \"9442384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LBP mediates LPS-induced disruption of tight junctions in cholangiocyte monolayers: siRNA knockdown of LBP (as well as TLR4 or c-Src) attenuates LPS-induced paracellular permeability increase and ZO-1 redistribution; LBP is required for LPS-induced tyrosine phosphorylation of occludin and ZO-1 and dephosphorylation of occludin on Thr residues.\",\n      \"method\": \"siRNA knockdown of LBP/TLR4/c-Src in normal rat cholangiocyte monolayers; permeability assays; immunostaining of tight junction proteins; Western blot for phosphorylation states\",\n      \"journal\": \"American journal of physiology. Gastrointestinal and liver physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean siRNA KD with specific phosphorylation and permeability readouts, single lab\",\n      \"pmids\": [\"17446308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"LBP is essential for controlling low-dose Gram-negative infection: LBP-deficient mice fail to control peritoneal Salmonella infection, and living Salmonella and E. coli depend on the presence of LBP to induce reactive oxygen species generation in human or murine macrophages.\",\n      \"method\": \"LBP-knockout mouse infection model; ROS generation assays in macrophages from LBP-deficient vs. wild-type mice\",\n      \"journal\": \"Pathobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO mouse model with defined cellular readout (ROS) and in vivo infection outcome, single lab review\",\n      \"pmids\": [\"10725789\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LBP gene expression in macrophages is regulated by the nuclear receptor LXR (liver X receptor) in a cell-type-specific manner: oxysterols or modified LDL loading induces LBP in macrophages but not liver in an LXR-dependent manner. Macrophage-specific LBP promotes foam cell survival (not cholesterol efflux) and atherogenesis, as bone marrow transplant from LBP-/- donors markedly reduces atherosclerotic lesion burden.\",\n      \"method\": \"LXR agonist treatment of macrophages; bone marrow transplantation into LDLR-/- recipients with Western diet; TUNEL staining of lesions; cholesterol efflux assays; macrophage survival assays under cholesterol loading\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — bone marrow transplant with defined mechanistic outcome (survival not efflux), LXR-dependence shown, multiple methods, single lab\",\n      \"pmids\": [\"24671012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hepatic LBP expression is induced by gut microbiota colonization through MYD88-dependent signaling. LBP potentiates LPS inhibition of insulin signaling in hepatocytes in the presence of low LPS; pharmacological LBP blockade (LBPK95A peptide) or CRISPR-Cas9 hepatic Lbp knockdown improves systemic glucose homeostasis in mice.\",\n      \"method\": \"Liver transcriptomics of germ-free vs. conventionally raised wild-type and Myd88-KO mice; primary hepatocyte insulin signaling assays with LPS ± LBP ± LBPK95A; CRISPR-Cas9 hepatic Lbp knockdown; glucose/insulin tolerance tests\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic KO, CRISPR knockdown, pharmacological blocking, and in vitro reconstitution all converging on same mechanistic conclusion\",\n      \"pmids\": [\"32305515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gastric cancer-derived LBP activates the TLR4/NF-κB pathway in intrahepatic macrophages to promote TGF-β1 secretion, which in turn activates hepatic stellate cells to form a fibrotic pre-metastatic niche in the liver, facilitating metastatic gastric cancer cell migration and invasion.\",\n      \"method\": \"Co-IP, DIA mass spectrometry, mRNA sequencing of THP-1 macrophages ± LBP, Western blot, ELISA, IF, Transwell invasion assays, intrasplenic injection mouse LM model, galunisertib TGF-β pathway inhibition\",\n      \"journal\": \"Journal of experimental & clinical cancer research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing mechanistic pathway, single lab\",\n      \"pmids\": [\"37789385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A 170-kDa cysteine protease from Prevotella intermedia cleaves both CD14 and LBP in a concentration-dependent manner, thereby modulating LPS virulence; cleavage decreases IL-1β mRNA expression in LPS-activated macrophage cell lines, an effect reversible by soluble CD14 addition.\",\n      \"method\": \"Zymographic analysis; incubation of CD14/LBP with P. intermedia culture supernatants; RT-PCR for IL-1β mRNA in U937/THP-1 cells; class-specific protease inhibitor/stimulator profiling\",\n      \"journal\": \"Archives of microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — biochemical characterization of protease plus functional cytokine readout, single lab\",\n      \"pmids\": [\"12728301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Residues Trp91 and Lys92 in the LBP amino acid region 86-99 are indispensable for LPS binding and for inhibition of LBP-LPS interaction; substitution of Arg94, Lys95, and Phe98 by Ala increases inhibitory potency, identifying Lys95 as a key residue in the LPS-binding site of LBP.\",\n      \"method\": \"Ala-scanning peptide library of LBP residues 86-99; competitive LBP-LPS binding inhibition assay\",\n      \"journal\": \"Journal of peptide science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — systematic mutagenesis (Ala-scan) with functional binding assay, single lab\",\n      \"pmids\": [\"11991204\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Peptides derived from LBP residues 86-99 inhibit LPS responses in vitro and in vivo; inhibitory potency correlates with ability to block LBP-LPS interaction; peptide amphipathicity (assessed by Ala mutants) is important for inhibitory activity; these peptides were ~500-fold more active in vivo than in vitro.\",\n      \"method\": \"LBP-LPS competitive binding assay; in vitro LPS-induced cytokine assays; in vivo mouse endotoxemia model\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — binding assay correlated with functional in vitro and in vivo outcomes, single lab\",\n      \"pmids\": [\"14577844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LBP deficiency in rats aggravates HFD-induced NAFLD through an epigenetic mechanism: loss of LBP results in pronounced alterations of H3K27ac at active enhancers, with C/EBPβ identified as a pivotal transcription factor and SCD as a downstream lipid metabolism effector driving NAFLD exacerbation.\",\n      \"method\": \"LBP-/- rat model; ChIP-seq for H3K27ac; RNA-seq; integrative enhancer-transcriptome analysis; identification of C/EBPβ as TF and SCD as downstream gene\",\n      \"journal\": \"Zoological research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO model with integrated epigenomic and transcriptomic analysis, single lab\",\n      \"pmids\": [\"38114435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LBP acts as an adapter catalyzing LPS transfer to CD14 to trigger pro-inflammatory responses; at high concentrations (as occur during acute inflammation), LBP can inhibit LPS bioactivity in vitro and in vivo. sCD14 promotes LPS efflux from mCD14 and transfers LPS to plasma lipoproteins, attenuating cell responses; these dual stimulatory/inhibitory mechanisms are concentration-dependent.\",\n      \"method\": \"Review integrating in vitro concentration-response experiments and in vivo mouse studies from multiple labs\",\n      \"journal\": \"Journal of endotoxin research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — synthesis of prior experimental evidence from multiple labs establishing dual concentration-dependent role\",\n      \"pmids\": [\"16176659\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"LBP mRNA is upregulated in lung tissue after both intravenous and intratracheal LPS challenge in rats, coinciding with increased CD14 mRNA; systemic LPS caused greater lung LBP upregulation than local challenge. This local induction may prime the lung for amplified LPS-mediated injury upon secondary exposure.\",\n      \"method\": \"Northern blot analysis of LBP and CD14 mRNA from lung tissue at serial time points after IV vs. IT LPS challenge; ELISA for inflammatory cytokines in serum and BAL\",\n      \"journal\": \"The Journal of surgical research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — Northern blot quantification of LBP induction in defined tissue compartments with mechanistic interpretation\",\n      \"pmids\": [\"9733616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LBP can reverse the amyloid/hypercoagulable state of fibrin in platelet-poor plasma from type 2 diabetes patients, indicating that LBP neutralizes LPS-driven fibrin amyloidogenesis through direct LPS binding.\",\n      \"method\": \"Scanning electron microscopy and confocal microscopy of fibrin clots from T2D patient plasma ± LBP addition; thioflavin-T fluorescence for amyloid detection\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — morphological assay only, mechanism inferred from known LPS-binding function, single lab\",\n      \"pmids\": [\"28851981\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LBP is a liver-derived acute-phase glycoprotein that binds longitudinally to LPS micelles and catalyzes sequential, multi-round transfer of individual LPS molecules first to CD14 (via electrostatic interactions at LBP residues including Lys92/Trp91/Lys95) and then from CD14 to the TLR4-MD2 signaling complex in a TLR4-dependent manner; at low concentrations LBP potentiates innate immune responses to Gram-negative bacteria and other amphiphilic bacterial PAMPs (LTA, lipopeptides), while at high concentrations it can inhibit LPS bioactivity; LBP gene transcription in hepatocytes is activated by IL-6/IL-1β through STAT-3, AP-1, and C/EBPβ promoter elements, and in macrophages by LXR-dependent cholesterol sensing; macrophage LBP promotes foam-cell survival and atherogenesis, and hepatic LBP (induced by gut microbiota via MYD88) potentiates LPS inhibition of insulin signaling, impairs glucose homeostasis, and in its absence drives NAFLD through C/EBPβ/SCD-mediated epigenetic dysregulation.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\nI'll systematically classify each paper before extracting discoveries.\n\n**Classification:**\n\nThe target gene is **LBP** = Lipopolysaccharide-Binding Protein (human acute-phase protein, ~60 kDa, binds LPS and transfers it to CD14/TLR4).\n\nPapers to EXCLUDE (alias collisions or unrelated):\n- Papers about \"LBP\" as Leucine Binding Protein (bacterial periplasmic, paper [48]) — EXCLUDE (symbol collision, bacterial protein)\n- Papers about \"LBP/p40\" or \"LBP-p40\" (laminin binding protein precursor, 37/67 kDa) — EXCLUDE ([39], [45], [64], [95])\n- Papers about \"LBP-1b\", \"LBP-9\", \"LBP-1c/CP2/LSF\" (transcription factors) — EXCLUDE ([23], [24], [37], [40], [52], [60], [79], [98])\n- Papers about Lycium barbarum Polysaccharide (LBP) — EXCLUDE ([29], [53], [57], [65])\n- Papers about cyanophage Ma-LBP — EXCLUDE ([27])\n- Papers about Streptococcus pyogenes Lbp (laminin-binding protein) — EXCLUDE ([19], [30])\n- Papers about Vitamin D receptor LBP (ligand binding pocket) — EXCLUDE ([21])\n- Papers about Liquid Based Preparation (LBP) cytology — EXCLUDE ([69])\n- Papers about Local Binary Patterns (LBP) facial recognition — EXCLUDE ([100])\n- Papers about LBP-4a (Lycium barbarum polysaccharide fraction) — EXCLUDE ([57])\n- Papers about Mycobacterium Lbp/Hlp — EXCLUDE ([87])\n- Papers about Arabidopsis AtLBR — EXCLUDE ([73]) — plant gene, fundamentally incompatible\n- Papers about invertebrate LBP/BPI orthologs (Biomphalaria, earthworm, mollusk, ark shell, cod BPI/LBP) — borderline; these describe clear orthologs of the BPI/LBP family but in non-mammalian organisms. The cod BPI/LBP and invertebrate LBPs are orthologs but their functional findings are about the invertebrate proteins specifically, not human LBP. I'll EXCLUDE these as they don't provide direct mechanistic findings about human LBP.\n- Papers about LBP/BPI in chicken egg (ovocalyxin) — EXCLUDE ([62])\n- Papers about BSP30/PSP/LBP superfamily in cattle saliva — EXCLUDE ([36])\n- Papers about p67 laminin binding protein (37/67 kDa LBP) — EXCLUDE ([58], [88], [45])\n- Additional curated papers: interactome maps, ribosome structures, cDNA collections — these are large-scale datasets where LBP may appear incidentally. EXCLUDE as they provide no specific mechanistic findings about LBP.\n- Paper [96] about \"LBP\" in hepatocellular carcinoma context — this uses \"LBP\" but refers to Lycium barbarum polysaccharide. EXCLUDE.\n- Paper [38] about gastric cancer LBP — this appears to be about LPS-binding protein LBP. KEEP.\n- Paper [83] about hepatic Lbp expression — KEEP (about LPS-binding protein).\n- Paper [90] about LBP in NAFLD — KEEP.\n- Paper [66] about macrophage LBP as LXR target — KEEP.\n\n**KEEP list:** [1], [4], [7], [8], [9], [10], [11], [12], [13], [14], [16], [22], [25], [31], [38], [41], [43], [46], [47], [49], [50], [51], [54], [55], [59], [66], [67], [71], [72], [82], [83], [84], [86], [90], [91], [93], [97]\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2016,\n      \"finding\": \"Reconstitution of the complete LPS transfer cascade in vitro revealed that a single LBP molecule binds longitudinally to LPS micelles and catalyzes multiple rounds of LPS transfer to CD14 via electrostatic interactions; CD14 rapidly dissociates from the LBP-LPS complex after receiving LPS, and the single LPS molecule on CD14 is then transferred to TLR4-MD2 in a TLR4-dependent manner. Structural determinants on LBP critical for LPS binding and transfer were defined by electron microscopy and single-molecule TIRF fluorescence analysis.\",\n      \"method\": \"In vitro reconstitution of LPS transfer cascade, negative-stain electron microscopy, single-molecule TIRF fluorescence microscopy, mutagenesis of charged residues\",\n      \"journal\": \"Immunity\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — full reconstitution in vitro with multiple orthogonal structural and single-molecule methods; replicated in companion BMB Reports paper\",\n      \"pmids\": [\"27986454\", \"28115037\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"LBP and BPI form physically distinct complexes with LPS: LBP disperses LPS aggregates (reducing apparent aggregate size), whereas BPI enhances sedimentation velocity and apparent size of LPS aggregates and inhibits LBP-LPS binding at very low BPI:LPS molar ratios, explaining their opposing functional consequences.\",\n      \"method\": \"Sedimentation analysis, light scattering, fluorescence spectroscopy of LPS-protein complexes\",\n      \"journal\": \"The Journal of Biological Chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple orthogonal biophysical methods on purified proteins; mechanistically definitive\",\n      \"pmids\": [\"9228038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"Structural analysis of conserved residues in BPI and LBP based on the BPI crystal structure identified that the most conserved regions form the interfaces of two apolar lipid-binding pockets, and a cluster of conserved positively charged residues at the tip of the N-terminal domain (corresponding to Lys42, 48, 92, 95, 99 in BPI) likely make electrostatic contacts with negatively charged LPS; the higher overall positive charge of BPI's N-terminal domain relative to LBP was proposed to underlie BPI's bactericidal activity.\",\n      \"method\": \"Comparative structural analysis using BPI crystal structure; sequence conservation mapping; homology modeling of human LBP\",\n      \"journal\": \"Protein Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 structure, but functional assignments are partly inferential from conservation; no LBP crystal structure\",\n      \"pmids\": [\"9568897\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"In human coronary artery endothelial cells (HCAEC), TLR4 functions intracellularly, and LBP is required for efficient LPS uptake by facilitating internalization of LPS-CD14 complexes to intracellular TLR4-MD2. LBP-dependent uptake involves a scavenger receptor pathway.\",\n      \"method\": \"FACS, confocal microscopy, RT-PCR, functional activation assays; inhibitor experiments\",\n      \"journal\": \"FASEB Journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods in primary cells with functional readout; single lab\",\n      \"pmids\": [\"15132988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"LBP is required for LPS-induced disruption of tight junctions in cholangiocyte monolayers: siRNA knockdown of LBP (alongside TLR4 and c-Src) attenuated LPS-induced paracellular permeability increase and redistribution of ZO-1, occludin, and claudin proteins. LBP acts upstream of c-Src and myosin light chain kinase in the signaling cascade leading to ZO-1 tyrosine phosphorylation.\",\n      \"method\": \"siRNA knockdown, permeability assays, immunofluorescence, Western blot for phosphorylation\",\n      \"journal\": \"American Journal of Physiology - Gastrointestinal and Liver Physiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific siRNA KD with defined molecular phenotype; single lab\",\n      \"pmids\": [\"17446308\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LBP transfers LPS to CD14 at low concentrations to enhance pro-inflammatory responses, but at high concentrations (as during acute-phase response) LBP inhibits LPS bioactivity. LBP also promotes LPS efflux from cell-surface mCD14 by transfer to plasma lipoproteins. Additionally, soluble CD14 can reverse monocyte LPS responses after binding without requiring extensive LPS release, whereas LBP inhibition after cell binding is independent of major LPS redistribution.\",\n      \"method\": \"In vitro cell activation assays, LPS binding/transfer experiments with purified proteins at varying concentrations\",\n      \"journal\": \"Journal of Endotoxin Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional assays with purified components; replicated across labs for the dual stimulatory/inhibitory dose-dependent effect\",\n      \"pmids\": [\"16176659\", \"12803885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"Monoclonal antibodies against murine LBP that either block LPS binding to LBP (class 1) or block LPS/LBP complex binding to CD14 (class 2) both suppressed LPS-induced TNF production and protected mice from lethal endotoxemia, demonstrating that LBP's critical function is to present LPS to CD14.\",\n      \"method\": \"Monoclonal antibody generation and characterization; in vivo LPS challenge model; TNF ELISA\",\n      \"journal\": \"Journal of Immunology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — mechanistic antibody blocking in vitro and in vivo; clear epistatic placement of LBP upstream of CD14\",\n      \"pmids\": [\"10358200\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Genetic deletion of LBP in mice with wild-type NRAMP1 renders them as susceptible to intraperitoneal Salmonella infection as NRAMP1-deficient mice, demonstrating that LBP is a critical non-redundant component of innate defense against Gram-negative bacterial infection in vivo.\",\n      \"method\": \"LBP knockout mouse model; in vivo bacterial infection challenge\",\n      \"journal\": \"Journal of Endotoxin Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean genetic KO with defined infectious phenotype; in vivo epistasis with NRAMP1\",\n      \"pmids\": [\"11753215\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LBP is incorporated as a membrane-spanning protein (mLBP) in the cytoplasmic membrane of mononuclear cells in addition to its role as a soluble serum protein. In this membrane configuration, mLBP binds endotoxin aggregates and transfers them to transmembrane signaling proteins. Pre-formed soluble LBP-LPS complexes, in contrast, do not interact with membranes and lead to LPS neutralization. FRET spectroscopy showed endotoxin aggregates are intercalated into reconstituted membranes by mLBP.\",\n      \"method\": \"Patch-clamp electrophysiology on excised membrane patches, fluorescence resonance energy transfer (FRET) spectroscopy, RT-PCR, cytokine assays\",\n      \"journal\": \"Journal of Endotoxin Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods; membrane intercalation shown by FRET and electrophysiology; single lab\",\n      \"pmids\": [\"12831460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"LBP interacts with planar lipid bilayers by intercalating in a directed (asymmetric) orientation into negatively charged membranes, adopting a transmembrane configuration. After intercalation, both anti-LBP antibodies and LPS can bind to LBP on both sides of the bilayer. Pre-incubated LPS-LBP complexes do not interact with membranes.\",\n      \"method\": \"Electrical measurements on planar lipid bilayers (membrane current, potential, capacitance); antibody binding assays\",\n      \"journal\": \"Biological Chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reconstituted system with functional readout; single lab\",\n      \"pmids\": [\"11347890\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"LBP binds to non-LPS bacterial amphiphilic compounds including lipoteichoic acid (LTA) from Gram-positive bacteria, LTA-like glycolipids from spirochetes, and lipopeptides from spirochetes, Mycobacterium, Gram-negative bacteria, and Mycoplasma, thereby modulating their ability to stimulate innate immune cells and their interaction with CD14.\",\n      \"method\": \"Binding assays; competitive LBP binding assay; cell stimulation assays\",\n      \"journal\": \"Journal of Endotoxin Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple ligands tested; replicated across labs for LTA (PMID 11828371); mechanistic breadth established\",\n      \"pmids\": [\"16176661\", \"11828371\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"Transcriptional activation of the LBP gene in hepatocytes requires intact STAT-3 binding sites in the LBP promoter, as demonstrated by nuclear run-on assays, RNA half-life measurements, and luciferase reporter assays with promoter mutation variants. IL-6 alone induces LBP transcription, while IL-1β augments the IL-6 effect.\",\n      \"method\": \"Nuclear run-on assays, RNA stability assays, luciferase reporter assays with LBP promoter deletion/mutation constructs\",\n      \"journal\": \"Cytokines, Cellular & Molecular Therapy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — reporter assays with mutagenesis; transcriptional mechanism defined\",\n      \"pmids\": [\"9287245\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1997,\n      \"finding\": \"The transcription factors AP-1 and C/EBPβ are required for LBP gene activation in hepatocytes: luciferase reporter assays and electromobility shift assays (EMSA) showed their binding to the LBP promoter, and stimulation with IL-1β, IL-6, TNF-α, and dexamethasone drives dose- and time-dependent LBP transcription.\",\n      \"method\": \"Luciferase reporter gene assays, electromobility shift assays (EMSA), Western blot\",\n      \"journal\": \"Immunobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA plus reporter assays; single lab; two transcription factors identified\",\n      \"pmids\": [\"9442384\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"LBP is a macrophage-specific LXR target gene: oxysterol treatment or modified-LDL loading induces LBP expression in macrophages but not liver in an LXR-dependent manner. Bone marrow transplant studies using LBP-/- donors showed markedly smaller atherosclerotic lesions and increased apoptosis in lesions, demonstrating that macrophage LBP promotes foam cell survival and atherogenesis without affecting cholesterol efflux.\",\n      \"method\": \"LXR agonist treatment, bone marrow transplantation, atherosclerosis lesion quantification, TUNEL staining, cholesterol efflux assay\",\n      \"journal\": \"Journal of Lipid Research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vivo KO transplant study with defined atherosclerosis phenotype plus in vitro mechanistic dissection; multiple methods\",\n      \"pmids\": [\"24671012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"A protease from the periodontal pathogen Prevotella intermedia cleaves both CD14 and LBP in a concentration-dependent manner, thereby reducing LPS virulence signaling. The enzyme is a membrane-associated 170-kDa cysteine protease that also cleaves membrane-associated CD14, as shown by decreased IL-1β mRNA induction in LPS-activated macrophage cell lines.\",\n      \"method\": \"Zymography, molecular mass analysis, class-specific inhibitor/activator profiling, RT-PCR for IL-1β mRNA\",\n      \"journal\": \"Archives of Microbiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — biochemical characterization of cleavage plus functional consequence; single lab\",\n      \"pmids\": [\"12728301\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Hepatic LBP expression is induced by gut microbiota through MYD88-dependent signaling. LBP potentiates LPS-induced inhibition of insulin signaling in hepatocytes at low LPS concentrations, and this effect is abolished by the LBP-blocking peptide LBPK95A. CRISPR-Cas9-mediated hepatic Lbp knockdown and systemic LBPK95A treatment both improve systemic glucose homeostasis in mice.\",\n      \"method\": \"Liver transcriptomics in germ-free vs. conventionally-raised Myd88-KO mice; primary hepatocyte insulin signaling assays; CRISPR-Cas9 hepatic KD; pharmacological LBP blockade in vivo\",\n      \"journal\": \"Molecular Metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple in vivo genetic models plus in vitro mechanistic assay; multiple orthogonal approaches\",\n      \"pmids\": [\"32305515\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Gastric cancer-derived LBP activates the TLR4/NF-κB pathway in intrahepatic macrophages to promote TGF-β1 secretion, which activates hepatic stellate cells to form a fibrotic pre-metastatic niche in the liver. TGF-β1 also enhances migration and invasion of metastatic gastric cancer cells. Shown by Co-IP, mRNA sequencing of LBP-treated macrophages, and intrasplenic injection mouse models.\",\n      \"method\": \"Co-immunoprecipitation, mRNA sequencing, flow cytometry, immunofluorescence, Western blot, intrasplenic injection mouse LM model, Transwell assays\",\n      \"journal\": \"Journal of Experimental & Clinical Cancer Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple methods; pathway placement via TLR4/NF-κB/TGF-β1 axis; single lab\",\n      \"pmids\": [\"37789385\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"LBP can reverse the amyloid (hypercoagulable) state of fibrin observed in plasma from type 2 diabetic patients with cardiovascular comorbidities, suggesting LBP neutralizes LPS-induced fibrin amyloidogenesis. The effect was demonstrated by scanning electron microscopy and confocal microscopy of clot ultrastructure.\",\n      \"method\": \"Scanning electron microscopy (SEM), confocal microscopy of clot ultrastructure; platelet-poor plasma from T2D patients treated with LBP\",\n      \"journal\": \"Scientific Reports\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — morphological assay only; no direct biochemical mechanism for LBP-fibrin interaction established\",\n      \"pmids\": [\"28851981\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Peptides corresponding to human LBP amino acid region 86–108 inhibit LPS-LBP interaction. Alanine-scanning of residues 86–99 identified Trp91 and Lys92 as indispensable for peptide-LPS binding; substitution of Arg94, Lys95, and Phe98 with Ala increased inhibitory potency, with the Lys95→Ala mutant most active in blocking LPS binding to LBP.\",\n      \"method\": \"Synthetic peptide alanine-scanning library; competitive LPS-binding assay; in vitro and in vivo LPS-response inhibition assays\",\n      \"journal\": \"Journal of Peptide Science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — systematic mutagenesis of LPS-binding region; functional validation in cell and animal assays\",\n      \"pmids\": [\"11991204\", \"14577844\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Directed evolution of the LBP C-terminal CD14-binding region identified that a Thr287→Met mutation in LBP significantly improves the anti-endotoxin activity of derived peptides, suggesting that residue 287 of the LBP C-terminus plays an important role in LBP-CD14 interaction.\",\n      \"method\": \"Error-prone PCR phage display library; competitive CD14-binding screen; in vitro TNF-α/NF-κB assays; in vivo LPS-induced ARDS rat model\",\n      \"journal\": \"PloS One\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — directed evolution plus functional in vitro and in vivo validation; single lab\",\n      \"pmids\": [\"25025695\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"LBP deficiency in rats aggravates high-fat diet-induced NAFLD despite reduced inflammation. Integrative H3K27ac ChIP-seq and transcriptomics revealed that LBP loss alters the histone acetylome, with C/EBPβ identified as a pivotal transcription factor driving dysregulated H3K27ac and the lipid metabolism gene SCD as a downstream effector mediating NAFLD exacerbation.\",\n      \"method\": \"LBP-/- rat model; H3K27ac ChIP-seq; transcriptomics; integrative bioinformatic analysis; Western blot validation\",\n      \"journal\": \"Zoological Research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — epigenomic association without direct biochemical demonstration of LBP-C/EBPβ interaction; single lab\",\n      \"pmids\": [\"38114435\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"LBP and soluble CD14 play distinct roles in LPS uptake by cells: LBP enables LPS binding and uptake by cells expressing membrane CD14, while soluble CD14 confers LPS responsiveness on cells lacking membrane CD14. Cell activation and LPS uptake were found to be independent phenomena with different protein requirements.\",\n      \"method\": \"LPS binding assays, cellular uptake assays, cell activation assays using purified recombinant LBP and sCD14\",\n      \"journal\": \"Progress in Clinical and Biological Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — purified proteins, cell-based functional assays; functional dissociation of uptake and activation\",\n      \"pmids\": [\"9575548\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"During sepsis, LBP (in addition to sCD14) promotes transfer of cell-bound LPS to plasma lipoproteins (primarily HDL), thereby attenuating monocyte LPS responses. In severe sepsis, the dominant LPS acceptor shifts from HDL to an acute-phase VLDL fraction with altered composition including apolipoprotein E and serum amyloid A.\",\n      \"method\": \"LPS binding/transfer assays in undiluted human serum; septic patient plasma analysis; lipoprotein fractionation\",\n      \"journal\": \"Journal of Endotoxin Research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional assays in human serum with patient samples; single lab; lipid transfer function demonstrated\",\n      \"pmids\": [\"12803885\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1998,\n      \"finding\": \"LBP and CD14 mRNA levels are co-induced in lung, kidney, and liver concurrently after cecal ligation and puncture (CLP) in mice, along with IL-1 mRNA, suggesting these organs become locally sensitized to a secondary LPS challenge through coordinated upregulation of the LPS recognition machinery.\",\n      \"method\": \"Northern blot, TaqMan fluorescent quantitative RT-PCR; CLP mouse model\",\n      \"journal\": \"The Journal of Surgical Research\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — mRNA expression data only; no direct mechanistic experiment beyond co-induction\",\n      \"pmids\": [\"9695742\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"LBP is a soluble acute-phase glycoprotein (~60 kDa) produced by hepatocytes under STAT-3, AP-1, and C/EBPβ transcriptional control in response to IL-6/IL-1β/TNF-α, and also expressed as a membrane-intercalated form in mononuclear cells; it binds longitudinally to LPS micelles and catalyzes multi-round transfer of LPS monomers to CD14 via electrostatic interactions, and the resulting CD14-LPS complex transfers LPS to TLR4-MD2 in a TLR4-dependent manner; at high concentrations LBP inhibits rather than enhances LPS signaling, and it additionally transfers LPS to plasma lipoproteins for neutralization, binds non-LPS bacterial amphiphiles (LTA, lipopeptides), intercalates into membranes to facilitate aggregate LPS transfer, is required in vivo for innate defense against Gram-negative bacteria, and in macrophages functions as an LXR target gene promoting foam cell survival and atherosclerosis while also potentiating LPS-driven inhibition of hepatic insulin signaling.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"LBP is an acute-phase glycoprotein that functions as a catalytic lipid-transfer protein in innate immunity, binding bacterial lipopolysaccharide (LPS) and other amphiphilic pathogen-associated molecular patterns and shuttling them to downstream pattern-recognition receptors. A single LBP molecule binds longitudinally to an LPS micelle and catalyzes multi-round extraction and transfer of individual LPS molecules to CD14 via electrostatic interactions involving residues Trp91, Lys92, and Lys95; CD14 then delivers a single LPS monomer to the TLR4–MD-2 signaling complex in a TLR4-dependent manner, and genetic ablation of LBP, CD14, or TLR4 each abolishes innate defense against Gram-negative infection [PMID:27986454, PMID:11753215, PMID:10358200]. LBP gene transcription in hepatocytes is driven by IL-6/IL-1β through STAT-3, AP-1, and C/EBPβ promoter elements, while macrophage-specific LBP is induced by LXR-dependent cholesterol sensing and promotes foam-cell survival and atherogenesis [PMID:9287245, PMID:24671012]. Hepatic LBP, induced by gut microbiota via MYD88, potentiates LPS-mediated inhibition of insulin signaling, and LBP deficiency exacerbates NAFLD through C/EBPβ/SCD-driven epigenetic dysregulation of lipid metabolism [PMID:32305515, PMID:38114435].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Establishing how LBP physically engages LPS differently from the structurally related protein BPI resolved the question of why two homologous proteins have opposing biological effects — LBP disaggregates LPS micelles for immune activation while BPI promotes aggregation for neutralization.\",\n      \"evidence\": \"Sedimentation, dynamic light scattering, and fluorescence assays comparing LBP–LPS versus BPI–LPS complexes in vitro\",\n      \"pmids\": [\"9228038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No high-resolution crystal structure of the LBP–LPS complex\",\n        \"Mechanism of LPS disaggregation at atomic level unresolved\"\n      ]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Identifying the cytokine signals and transcription factors governing LBP induction established LBP as a bona fide acute-phase gene regulated at the transcriptional level by IL-6/IL-1β through STAT-3, AP-1, and C/EBPβ elements.\",\n      \"evidence\": \"Nuclear run-on, RNA half-life, promoter–reporter, and EMSA in hepatocytes\",\n      \"pmids\": [\"9287245\", \"9442384\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Chromatin-level regulation (e.g., enhancer accessibility) not characterized\",\n        \"Post-translational regulation of LBP protein levels not addressed\"\n      ]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Mapping the LPS-binding site to conserved positively charged residues at the N-terminal tip (using the BPI crystal structure as template) provided the first structural framework for LBP–LPS recognition, though it relied on homology modeling rather than direct LBP structural data.\",\n      \"evidence\": \"Comparative sequence analysis of BPI/LBP family mapped onto BPI crystal coordinates\",\n      \"pmids\": [\"9568897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No experimental LBP crystal structure to confirm modeled binding site\",\n        \"Lipid pocket occupancy in LBP not directly demonstrated\"\n      ]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Demonstrating that monoclonal antibodies blocking either LBP–LPS binding or LBP–LPS→CD14 transfer both protect mice from lethal endotoxemia proved that LBP operates through a two-step sequential mechanism in vivo.\",\n      \"evidence\": \"Two classes of anti-LBP monoclonal antibodies tested in mouse endotoxemia model with TNF readout\",\n      \"pmids\": [\"10358200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Kinetics of each transfer step in vivo not quantified\",\n        \"Whether antibody-resistant LBP-independent pathways exist at high LPS doses not resolved\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic epistasis using LBP, CD14, and TLR4 single-knockout mice placed LBP as an essential upstream component of the innate LPS-sensing cascade required for defense against live Gram-negative infection.\",\n      \"evidence\": \"LBP−/−, CD14−/−, TLR4−/− mice on NRAMP1-WT background challenged with Salmonella; survival analysis\",\n      \"pmids\": [\"11753215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Redundancy with other LPS-binding proteins in non-peritoneal infection models not tested\",\n        \"Whether LBP is required for all TLR4-dependent signaling or only LPS-mediated signaling unclear\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Alanine-scanning mutagenesis of LBP residues 86–99 pinpointed Trp91 and Lys92 as indispensable for LPS binding and identified Lys95 as a modulator, providing the first direct mutational map of the LBP LPS-binding site.\",\n      \"evidence\": \"Ala-scanning peptide library of LBP(86–99) tested in competitive LBP–LPS binding assay\",\n      \"pmids\": [\"11991204\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mutations tested only as peptide competitors, not in full-length LBP protein\",\n        \"Structural basis for individual residue contributions not resolved\"\n      ]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"The discovery of a membrane-inserted form of LBP (mLBP) on mononuclear cells, capable of intercalating endotoxin aggregates into membranes, revealed a second mode of LBP action distinct from the canonical soluble transfer mechanism.\",\n      \"evidence\": \"RT-PCR for mLBP; FRET spectroscopy; patch-clamp on macrophage membranes\",\n      \"pmids\": [\"12831460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Transmembrane topology of mLBP not independently validated (e.g., by cross-linking or protease protection)\",\n        \"Physiological relevance of mLBP versus soluble LBP not quantified in vivo\"\n      ]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Showing that LBP binds diverse amphiphilic PAMPs beyond LPS — including LTA, spirochetal glycolipids, and lipopeptides — broadened LBP's role from an LPS-specific shuttle to a general pattern-recognition transfer protein for amphiphilic microbial products.\",\n      \"evidence\": \"Competitive LBP binding assays (IC50) and TNF induction assays with and without LBP for multiple PAMPs\",\n      \"pmids\": [\"16176661\", \"11828371\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether LBP uses the same binding pocket for all PAMPs or distinct sites is unresolved\",\n        \"Functional relevance of LBP-dependent LTA recognition in vivo not established\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identifying LXR-dependent LBP expression in macrophages and showing via bone marrow transplantation that macrophage-derived LBP promotes foam-cell survival and atherogenesis established a cell-autonomous, pro-atherogenic role for LBP independent of hepatic production.\",\n      \"evidence\": \"LXR agonist treatment; bone marrow transplant from LBP−/− donors into LDLR−/− mice on Western diet; lesion quantification, TUNEL, and survival assays\",\n      \"pmids\": [\"24671012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Mechanism by which LBP promotes foam-cell survival is not molecularly defined\",\n        \"Whether macrophage LBP signals through TLR4 or alternative receptors in this context not shown\"\n      ]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Full reconstitution of the entire LPS transfer cascade — from LBP on the micelle through CD14 to TLR4–MD-2 — at the single-molecule level established that one LBP molecule catalyzes multiple rounds of LPS extraction and that CD14→TLR4 transfer requires TLR4 itself.\",\n      \"evidence\": \"Negative-stain EM; single-molecule TIRF fluorescence; charged-residue mutagenesis\",\n      \"pmids\": [\"27986454\", \"28115037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Atomic-resolution structure of the LBP–LPS–CD14 ternary intermediate not available\",\n        \"How TLR4 catalyzes LPS release from CD14 is mechanistically undefined\"\n      ]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Demonstrating that gut microbiota induce hepatic LBP via MYD88 and that LBP potentiates LPS-mediated insulin resistance linked LBP to metabolic endotoxemia and glucose homeostasis, opening a microbiome–LBP–metabolism axis.\",\n      \"evidence\": \"Germ-free vs. conventional mice; Myd88-KO transcriptomics; CRISPR hepatic Lbp knockdown; LBPK95A peptide; glucose/insulin tolerance tests\",\n      \"pmids\": [\"32305515\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether LBP acts solely through TLR4 in hepatocytes or engages additional receptors not determined\",\n        \"Human relevance of hepatic LBP targeting for metabolic disease not clinically validated\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Showing that LBP deficiency worsens NAFLD through H3K27ac-driven epigenetic reprogramming of C/EBPβ/SCD targets revealed that LBP has a protective role in hepatic lipid homeostasis, paradoxically opposite to its insulin-resistance-promoting role.\",\n      \"evidence\": \"LBP−/− rat model; ChIP-seq (H3K27ac); RNA-seq; integrative enhancer analysis\",\n      \"pmids\": [\"38114435\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which LBP presence restrains C/EBPβ-driven enhancer activation is unknown\",\n        \"Discrepancy between LBP promoting insulin resistance yet protecting against NAFLD not reconciled\",\n        \"Findings in rat model; species-specific differences not assessed\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution structure of the LBP–LPS complex and of the LBP–LPS–CD14 transfer intermediate is still lacking, and the mechanism by which concentration-dependent switching between pro-inflammatory and anti-inflammatory LBP activity occurs at the molecular level remains undefined.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"No crystal or cryo-EM structure of LBP alone or in complex with LPS/CD14\",\n        \"Molecular basis for dual concentration-dependent activation/inhibition not resolved\",\n        \"Relative contributions of soluble versus membrane-bound LBP in vivo unknown\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 2, 3, 19]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 1, 5, 22]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [9, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 5, 9, 22]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [7, 8]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 5, 6, 10, 14]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 4, 17]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [16, 21]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"CD14\",\n      \"TLR4\",\n      \"MD2\",\n      \"CEBPB\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"LBP is a soluble acute-phase glycoprotein that functions as the principal initiator of innate immune recognition of lipopolysaccharide (LPS) and other bacterial amphiphiles by catalyzing their transfer to CD14 and, subsequently, to the TLR4–MD-2 signaling complex [PMID:27986454, PMID:10358200]. A single LBP molecule binds longitudinally to LPS micelles and executes multiple rounds of monomer extraction via electrostatic interactions involving N-terminal residues Trp91/Lys92, while its C-terminal domain mediates CD14 docking; at high acute-phase concentrations LBP instead diverts LPS to plasma lipoproteins for neutralization, conferring a dose-dependent switch between pro- and anti-inflammatory outcomes [PMID:27986454, PMID:16176659, PMID:12803885]. LBP also recognizes lipoteichoic acid and bacterial lipopeptides, and in vivo LBP deficiency renders mice critically susceptible to Gram-negative infection [PMID:16176661, PMID:11753215]. Beyond classical innate immunity, macrophage-expressed LBP is an LXR target gene that promotes foam-cell survival and atherogenesis, and hepatic LBP potentiates LPS-driven inhibition of insulin signaling in a microbiota- and MYD88-dependent manner [PMID:24671012, PMID:32305515].\",\n  \"teleology\": [\n    {\n      \"year\": 1997,\n      \"claim\": \"Defining LBP's transcriptional control resolved how acute-phase induction is regulated: STAT-3, AP-1, and C/EBPβ binding sites in the LBP promoter are required for hepatocyte transcription driven by IL-6, IL-1β, TNF-α, and dexamethasone.\",\n      \"evidence\": \"Nuclear run-on, RNA stability, luciferase reporter, and EMSA assays in hepatocyte lines\",\n      \"pmids\": [\"9287245\", \"9442384\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No ChIP-seq confirmation of in vivo TF occupancy\", \"Relative contribution of each TF at endogenous locus not quantified\"]\n    },\n    {\n      \"year\": 1997,\n      \"claim\": \"Biophysical analysis established that LBP and BPI have opposing effects on LPS aggregates—LBP disperses while BPI stabilizes them—explaining their antagonistic roles in endotoxin biology.\",\n      \"evidence\": \"Sedimentation analysis, light scattering, and fluorescence spectroscopy with purified proteins\",\n      \"pmids\": [\"9228038\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution structure of LBP–LPS complex\", \"Relative kinetics of BPI competition in serum not determined\"]\n    },\n    {\n      \"year\": 1998,\n      \"claim\": \"Homology modeling from the BPI crystal structure predicted that conserved positively charged residues at the N-terminal tip and two apolar lipid-binding pockets constitute the LPS-binding architecture of LBP.\",\n      \"evidence\": \"Comparative structural analysis and conservation mapping based on BPI crystal structure\",\n      \"pmids\": [\"9568897\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No experimental LBP crystal structure obtained\", \"Functional roles of individual pockets not tested by mutagenesis at this stage\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"Monoclonal antibodies that block either LPS–LBP or LBP–CD14 interaction both protected mice from lethal endotoxemia, establishing in vivo that LBP's essential function is to present LPS to CD14.\",\n      \"evidence\": \"Blocking mAbs against murine LBP; in vivo LPS challenge and TNF ELISA\",\n      \"pmids\": [\"10358200\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Antibody epitopes not mapped to atomic resolution\", \"Contribution of LPS-to-lipoprotein shunting not distinguished from CD14 presentation\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Genetic deletion of LBP demonstrated it is a non-redundant innate defense factor: LBP-knockout mice were as susceptible to Salmonella as NRAMP1-deficient mice.\",\n      \"evidence\": \"LBP−/− mouse model with intraperitoneal Salmonella challenge\",\n      \"pmids\": [\"11753215\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Susceptibility to Gram-positive infection not tested\", \"Compensatory pathways in the absence of LBP not characterized\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Discovery that LBP also exists as a membrane-intercalated form (mLBP) in mononuclear cells expanded the functional model beyond a soluble opsonin, showing mLBP transfers LPS aggregates directly into membranes.\",\n      \"evidence\": \"Patch-clamp electrophysiology, FRET spectroscopy on reconstituted bilayers, and planar lipid bilayer assays\",\n      \"pmids\": [\"12831460\", \"11347890\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Topology and stoichiometry of mLBP in native cell membranes not resolved\", \"Relative contribution of mLBP versus soluble LBP to physiological signaling unknown\"]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Alanine-scanning mutagenesis of LBP residues 86–108 identified Trp91 and Lys92 as indispensable for LPS binding and showed that the K95A substitution paradoxically enhanced anti-endotoxin potency of derived peptides, mapping the minimal LPS-interaction motif.\",\n      \"evidence\": \"Synthetic peptide library with competitive LPS-binding and in vitro/in vivo inhibition assays\",\n      \"pmids\": [\"11991204\", \"14577844\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No co-crystal structure of peptide–LPS complex\", \"Peptide effects not validated in full-length LBP context\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"The dose-dependent duality of LBP was mechanistically resolved: low-concentration LBP transfers LPS to CD14 for cell activation, whereas high-concentration LBP promotes LPS efflux to lipoproteins for neutralization, explaining the acute-phase regulatory logic.\",\n      \"evidence\": \"In vitro cell activation and LPS-transfer assays with purified proteins at varying concentrations; lipoprotein fractionation from septic plasma\",\n      \"pmids\": [\"16176659\", \"12803885\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Threshold concentrations in vivo not defined\", \"Structural basis for the concentration-dependent switch not determined\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"LBP's ligand repertoire was expanded beyond LPS to include lipoteichoic acid, spirochetal glycolipids, and bacterial lipopeptides, establishing it as a broad-spectrum pattern recognition cofactor.\",\n      \"evidence\": \"Competitive binding assays and cell stimulation assays with Gram-positive and atypical bacterial amphiphiles\",\n      \"pmids\": [\"16176661\", \"11828371\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding affinities for non-LPS ligands not quantified comparatively\", \"In vivo relevance for Gram-positive defense not shown genetically\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identification of LBP as a macrophage LXR target gene that promotes foam-cell survival and atherosclerosis linked LBP function to metabolic disease beyond infection, via a cholesterol-efflux-independent mechanism.\",\n      \"evidence\": \"LXR agonist treatment, bone marrow transplant of LBP−/− donors, atherosclerosis lesion quantification, TUNEL staining\",\n      \"pmids\": [\"24671012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Downstream survival pathway in foam cells not identified\", \"Whether LBP promotes atherogenesis through LPS-dependent or -independent signaling is unresolved\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"Full in vitro reconstitution of the LPS transfer cascade demonstrated that one LBP molecule catalyzes multiple rounds of LPS monomer extraction from micelles and delivery to CD14, which then hands off a single LPS to TLR4–MD-2 in a TLR4-dependent step, providing the complete quantitative mechanism.\",\n      \"evidence\": \"Reconstituted cascade with negative-stain EM and single-molecule TIRF fluorescence microscopy\",\n      \"pmids\": [\"27986454\", \"28115037\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the ternary LBP–LPS–CD14 transfer intermediate still lacking\", \"Catalytic cycle rate constants not measured under physiological membrane conditions\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Hepatic LBP was shown to be induced by gut microbiota via MYD88 and to potentiate LPS-driven inhibition of insulin signaling, connecting the LPS sensing axis to metabolic homeostasis; hepatic LBP knockdown or peptide blockade improved glucose tolerance.\",\n      \"evidence\": \"Germ-free vs. conventional and Myd88-KO mice; CRISPR hepatic KD; LBPK95A peptide in vivo; primary hepatocyte insulin signaling\",\n      \"pmids\": [\"32305515\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct molecular target of LBP in insulin signaling cascade not identified\", \"Contribution of intestinal vs. hepatic LBP pools not separated\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"A high-resolution crystal or cryo-EM structure of the LBP–LPS–CD14 transfer intermediate and the structural basis for LBP's concentration-dependent switch between pro-inflammatory transfer and lipoprotein shunting remain unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No atomic-resolution LBP structure solved\", \"Mechanism of mLBP membrane insertion not structurally characterized\", \"In vivo role of LBP in Gram-positive versus Gram-negative defense not genetically dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [0, 1, 2, 10, 18]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [0, 5, 6, 21]},\n      {\"term_id\": \"GO:0140104\", \"supporting_discovery_ids\": [0, 5, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005576\", \"supporting_discovery_ids\": [0, 1, 5, 6, 22]},\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [8, 9]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0, 6, 7, 10]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 4, 15, 16]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [13, 16]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"CD14\", \"TLR4\", \"MD-2\", \"BPI\"],\n    \"other_free_text\": []\n  }\n}\n```"}